COVID-19 (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "COVID-19" in Galician language version.

refsWebsite

Global rank Galician rank

88doi.org

2^nd place

7^th place

82nih.gov

4^th place

6^th place

55web.archive.org

1^st place

29cdc.gov

218^th place

235^th place

26who.int

195^th place

178^th place

18worldcat.org

5^th place

11^th place

7reuters.com

49^th place

168^th place

5fda.gov

447^th place

749^th place

5ourworldindata.org

2,263^rd place

6,904^th place

4europa.eu

68^th place

75^th place

4nature.com

234^th place

113^th place

4vox.com

484^th place

2,515^th place

4bmj.com

1,226^th place

970^th place

3portaldaspalabras.gal

low place

4^th place

3thelancet.com

2,393^rd place

2,657^th place

3bbc.com

20^th place

94^th place

3sciencemag.org

857^th place

242^nd place

2academia.gal

low place

2^nd place

2worldometers.info

2,099^th place

1,019^th place

2harvard.edu

18^th place

38^th place

2thespinoff.co.nz

5,412^th place

low place

2hopkinsmedicine.org

5,712^th place

6,650^th place

2nytimes.com

7^th place

32^nd place

2sciencealert.com

5,043^rd place

low place

2iss.it

low place

2merriam-webster.com

209^th place

192^nd place

2aifa.gov.it

low place

1mscbs.gob.es

low place

1entnet.org

low place

1sciencedaily.com

993^rd place

587^th place

1gov.uk

432^nd place

898^th place

1washingtonpost.com

34^th place

157^th place

1entuk.org

low place

1ssrn.com

703^rd place

2,480^th place

1elsevier.com

610^th place

214^th place

1annals.org

low place

6,362^nd place

1nautil.us

low place

1chinacdc.cn

low place

1theguardian.com

12^th place

64^th place

1nap.edu

2,128^th place

1,408^th place

1archive.org

6^th place

8^th place

1globenewswire.com

2,614^th place

low place

1businessinsider.com

140^th place

419^th place

1uconn.edu

5,165^th place

3,958^th place

1acr.org

low place

1npr.org

92^nd place

346^th place

1nhc.gov.cn

low place

1chp.gov.hk

low place

1bostonglobe.com

553^rd place

2,954^th place

1webmd.com

1,169^th place

841^st place

1sciencedirect.com

149^th place

162^nd place

1covid19evidence.net.au

low place

1nice.org.uk

3,258^th place

low place

1emcrit.org

low place

1upenn.edu

702^nd place

677^th place

1nhs.uk

1,989^th place

2,769^th place

1hfsa.org

low place

1heart.org

8,639^th place

6,555^th place

1escardio.org

low place

1ebmedicine.net

low place

7,518^th place

1jamanetwork.com

2,650^th place

5,312^th place

1imperial.ac.uk

7,025^th place

8,653^rd place

1handle.net

102^nd place

163^rd place

1meduza.io

444^th place

low place

13dprintingmedia.network

low place

1symmetrymagazine.org

low place

269^th place

1clinicaltrialsarena.com

low place

1technologyreview.com

1,943^rd place

1,087^th place

1govinsider.asia

low place

1politico.eu

1,347^th place

5,404^th place

1heise.de

766^th place

7,669^th place

1post-gazette.com

569^th place

1,860^th place

1bundesregierung.de

5,817^th place

low place

1datenschutzbeauftragter-info.de

low place

1err.ee

1,990^th place

3,785^th place

1aappublications.org

3,763^rd place

3,502^nd place

1immunology.org

low place

8,509^th place

1independent.co.uk

36^th place

150^th place

1latimes.com

22^nd place

93^rd place

1caixinglobal.com

low place

1scmp.com

362^nd place

2,734^th place

1todayonline.com

2,806^th place

low place

1economist.com

254^th place

388^th place

1fundeu.es

2,329^th place

1,246^th place

1nejm.org

2,374^th place

1,808^th place

1sergas.gal

low place

501^st place

1brusselstimes.com

8,796^th place

low place

1ing.dk

low place

1un.org

97^th place

57^th place

1koreabiomed.com

low place

1chinalawtranslate.com

low place

1chinaxiv.org

low place

1ansa.it

493^rd place

2,225^th place

1ilmessaggero.it

1,738^th place

3,098^th place

1fiercepharma.com

low place

1longislandpress.com

9,436^th place

low place

1jhu.edu

699^th place

519^th place

3dprintingmedia.network

"[Updating] Italian hospital saves Covid-19 patients lives by 3D printing valves for reanimation devices". 3D Printing Media Network. 14 de marzo de 2020. Consultado o 20 de marzo de 2020.

aappublications.org

pediatrics.aappublications.org

Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S (2020). "Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China" (PDF). Pediatrics: e20200702. PMID 32179660. doi:10.1542/peds.2020-0702.

academia.gal

Definicións no Dicionario da Real Academia Galega e no Portal das Palabras para covid-19.
Definicións no Dicionario da Real Academia Galega e no Portal das Palabras para sida.

acr.org

"ACR Recommendations for the use of Chest Radiography and Computed Tomography (CT) for Suspected COVID-19 Infection". American College of Radiology. 2020-03-22.

aifa.gov.it

"AIFA e Gilead annunciano che l'Italia è tra i Paesi che testeranno l'antivirale remdesivir per il trattamento del COVID-19". aifa.gov.it (en italiano). Consultado o 19 de marzo de 2020.
"Azioni intraprese per favorire la ricerca e l'accesso ai nuovi farmaci per il trattamento del COVID-19". aifa.gov.it (en italiano). Consultado o 18 de marzo de 2020.

annals.org

Lauer, Stephen A.; Grantz, Kyra H.; Bi, Qifang; Jones, Forrest K.; Zheng, Qulu; Meredith, Hannah R.; Azman, Andrew S.; Reich, Nicholas G.; Lessler, Justin (10 de marzo de 2020). "The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application". Annals of Internal Medicine (en inglés). ISSN 0003-4819. PMC 7081172. PMID 32150748. doi:10.7326/M20-0504. Arquivado dende o orixinal o 24 de marzo de 2020. Consultado o 28 de marzo de 2020.

ansa.it

"3 patients get better on arthritis drug". 5 de marzo de 2020. Consultado o 14 de marzo de 2020.

archive.org

Hamming, I.; Timens, W.; Bulthuis, M. L. C.; Lely, A. T.; Navis, G. J.; Goor, H. van (2004). "Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis". The Journal of Pathology (en inglés) 203 (2): 631–637. ISSN 1096-9896. PMID 15141377. doi:10.1002/path.1570.

bbc.com

"China launches coronavirus 'close contact' app". BBC News. 11 de febreiro de 2020. Consultado o 7 de marzo de 2020.
Tidy, Joe (17 de marzo de 2020). "Coronavirus: Israel enables emergency spy powers". BBC News (en inglés). Consultado o 18 de marzo de 2020.
Roberts M (17 de marzo de 2020). "Coronavirus: US volunteers test first vaccine". BBC News (en inglés). Consultado o 17 de marzo de 2020.

bmj.com

Day, Michael (17 de marzo de 2020). "Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists". BMJ 368: m1086. PMID 32184201. doi:10.1136/bmj.m1086. Consultado o 18 de marzo de 2020.
Day, Michael (17 de marzo de 2020). "Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists". BMJ (en inglés) 368: m1086. ISSN 1756-1833. PMID 32184201. doi:10.1136/bmj.m1086.

jcp.bmj.com

Autopsy in suspected COVID-19 cases, Hanley B et al, J Clin Pathol, PMID 32198191

bestpractice.bmj.com

Beeching NJ, Fletcher TE, Fowler R (2020). "BMJ Best Practices: COVID-19" (PDF). BMJ.

bostonglobe.com

"Guidance against wearing masks for the coronavirus is wrong – you should cover your face - The Boston Globe". BostonGlobe.com.

brusselstimes.com

Gato infectado en Bélxica

bundesregierung.de

"Kreative Lösungen gesucht". Startseite (en alemán). Arquivado dende o orixinal o 24 de marzo de 2020. Consultado o 28 de marzo de 2020.

businessinsider.com

Brueck H (30 de xaneiro de 2020). "There's only one way to know if you have the coronavirus, and it involves machines full of spit and mucus". Business Insider. Arquivado dende o orixinal o 1 de febreiro de 2020. Consultado o 1 de febreiro de 2020.

caixinglobal.com

"14% of Recovered Covid-19 Patients in Guangdong Tested Positive Again—Caixin Global". www.caixinglobal.com (en inglés). Consultado o 15 de marzo de 2020.

cdc.gov

"Coronavirus Disease 2019 (COVID-19) Symptoms". Centers for Disease Control and Prevention. United States. 10 de febreiro de 2020. Arquivado dende o orixinal o 30 de xaneiro de 2020.
"How COVID-19 Spreads". U.S. Centers for Disease Control and Prevention (CDC). 2 de abril de 2020. Arquivado dende o orixinal o 3 de abril de 2020. Consultado o 3 de abril de 2020.
"Coronavirus Disease 2019 (COVID-19) - Transmission". Centers for Disease Control and Prevention (en inglés). 17 de marzo de 2020. Consultado o 23 de marzo de 2020.
"Symptoms of Novel Coronavirus (2019-nCoV)". www.cdc.gov. 10 de febreiro de 2020. Arquivado dende o orixinal o 30 de xaneiro de 2020. Consultado o 11 de febreiro de 2020.
"Coronavirus Disease 2019 (COVID-19)". Centers for Disease Control and Prevention (en inglés). 11 de febreiro de 2020. Consultado o 26 de marzo de 2020.
CDC (11 de febreiro de 2020). "2019 Novel Coronavirus (2019-nCoV)". Centers for Disease Control and Prevention. Arquivado dende o orixinal o 14 de febreiro de 2020. Consultado o 15 de febreiro de 2020.
"Coronavirus Disease 2019 (COVID-19)". Centers for Disease Control and Prevention (CDC). 15 de febreiro de 2020. Arquivado dende o orixinal o 26 de febreiro de 2020. Consultado o 20 de febreiro de 2020.
"Coronavirus Disease 2019 (COVID-19)—Symptoms". Centers for Disease Control and Prevention (en inglés). 20 de marzo de 2020. Consultado o 21 de marzo de 2020.
"Coronavirus Disease 2019 (COVID-19)". Centers for Disease Control and Prevention (en inglés). 11 de febreiro de 2020.
"2019 Novel Coronavirus (2019-nCoV)". Centers for Disease Control and Prevention. 11 de febreiro de 2020. Arquivado dende o orixinal o 7 de marzo de 2020. Consultado o 18 de febreiro de 2020. O virus pénsase que se espalla principalmente de persoa a persoa ... por medio das pinguiñas respiratorias producidas cando unha persoa infectada tose ou espirra.
"Coronavirus Disease 2019 (COVID-19)—Transmission". Centers for Disease Control and Prevention (en inglés). 17 de marzo de 2020. Consultado o 29 March 2020.
Water Transmission and COVID-19 (CDC, consultado o 19 de marzo de 2020)
CDC (5 de febreiro de 2020). "CDC Tests for 2019-nCoV". Centers for Disease Control and Prevention. Arquivado dende o orixinal o 14 de febreiro de 2020. Consultado o 12 de febreiro de 2020.
"2019 Novel Coronavirus (2019-nCoV) Situation Summary". Centers for Disease Control and Prevention. 30 de xaneiro de 2020. Arquivado dende o orixinal o 26 de xaneiro de 2020. Consultado o 30 de xaneiro de 2020.
"Real-Time RT-PCR Panel for Detection 2019-nCoV". Centers for Disease Control and Prevention. 29 de xaneiro de 2020. Arquivado dende o orixinal o 30 de xaneiro de 2020. Consultado o 1 de febreiro de 2020.
Centers for Disease Control (3 de febreiro de 2020). "Coronavirus Disease 2019 (COVID-19): Prevention & Treatment" (en inglés). Arquivado dende o orixinal o 15 de decembro de 2019. Consultado o 10 de febreiro de 2020.
"Coronavirus Disease 2019 (COVID-19)—Prevention & Treatment". Centers for Disease Control and Prevention. U.S. Department of Health & Human Services. 10 de marzo de 2020.
Centers for Disease Control and Prevention (11 de febreiro de 2020). "What to do if you are sick with 2019 Novel Coronavirus (2019-nCoV)" (en inglés). Arquivado dende o orixinal o 14 de febreiro de 2020. Consultado o 13 de febreiro de 2020.
"Sequence for Putting On Personal Protective Equipment (PPE)" (PDF). CDC. Consultado o 8 de marzo de 2020.
U.S. Centers for Disease Control and Prevention (5 de abril de 2020). "What to Do if You Are Sick". Centers for Disease Control and Prevention (CDC). Arquivado dende o orixinal o 14 de febreiro de 2020. Consultado o 24 de abril de 2020.
Filtering out Confusion: Frequently Asked Questions about Respiratory Protection, User Seal Check. The National Institute for Occupational Safety and Health (abril de 2018). Consultado o 16 de marzo de 2020.
"Coronavirus Disease 2019 (COVID-19)". Centers for Disease Control and Prevention. 11 de febreiro de 2020. Consultado o 11 de marzo de 2020.
"Coronavirus Disease 2019 (COVID-19)". Centers for Disease Control and Prevention. 11 de febreiro de 2020. Consultado o 8 de marzo de 2020.
"Strategies for Optimizing the Supply of Eye Protection". CDC. 11 de febreiro de 2020.
CDC (11 de febreiro de 2020). "Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings". Centers for Disease Control and Prevention (en inglés). Consultado o 25 de marzo de 2020.
"Strategies for Optimizing the Supply of Facemasks". CDC. 11 de febreiro de 2020.
"Coronavirus Disease 2019 (COVID-19)". Centers for Disease Control and Prevention. 11 de febreiro de 2020. Consultado o 2 de marzo de 2020.
"Principles of Epidemiology | Lesson 3—Section 3". www.cdc.gov (en inglés). 18 de febreiro de 2019. Consultado o 28 de marzo de 2020.

blogs.cdc.gov

Proper N95 Respirator Use for Respiratory Protection Preparedness. NIOSH Science Blog (16 de marzo de 2020). Consultado o 16 de marzo de 2020.

chinacdc.cn

weekly.chinacdc.cn

Yanping Z, et al. (17 de febreiro de 2020). The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, ed. "The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19)—China, 2020". China CDC Weekly (Chinese Center for Disease Control and Prevention) 2 (8): 113–122. Consultado o 18 de marzo de 2020.

chinalawtranslate.com

"Novel Coronavirus Pneumonia Diagnosis and Treatment Plan (Provisional 7th Edition)". China Law Translate. 4 de marzo de 2020.

chinaxiv.org

"Effective Treatment of Severe COVID-19 Patients with Tocilizumab". ChinaXiv.org. 5 de marzo de 2020. doi:10.12074/202003.00026 (inactivo 2020-03-16). Consultado o 14 de marzo de 2020.

chp.gov.hk

"Prevention of Coronavirus Disease 2019 (COVID-19)" (PDF). Centre for Health Protection. Arquivado dende o orixinal (PDF) o 21 de marzo de 2020. Consultado o 22 de marzo de 2020. O uso de máscaras quirúrxicas cando se usa o transporte público ou en sitios ateigados.

clinicaltrialsarena.com

Duddu P (19 de febreiro de 2020). "Coronavirus outbreak: Vaccines/drugs in the pipeline for Covid-19". clinicaltrialsarena.com. Arquivado dende o orixinal o 19 de febreiro de 2020.

covid19evidence.net.au

"Home". National COVID-19 Clinical Evidence Taskforce (en inglés). Arquivado dende o orixinal o 11 de outubro de 2020. Consultado o 2020-07-11.

datenschutzbeauftragter-info.de

Dannewitz, Juliane (23 de marzo de 2020). "Hackathon Germany: #WirvsVirus". Datenschutzbeauftragter (en alemán).

doi.org

dx.doi.org

Hui, D. S.; I. Azhar E.; Madani, T. A.; Ntoumi, F.; Kock, R.; Dar, O.; Ippolito, G.; Mchugh, T. D.; Memish, Z. A.; Drosten, Christian; Zumla, A.; Petersen, E. (febreiro de 2020). "The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China". Int J Infect Dis 91: 264–66. PMID 31953166. doi:10.1016/j.ijid.2020.01.009.
Stadnytskyi V, Bax CE, Bax A, Anfinrud P (xuño de 2020). "The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission". Proceedings of the National Academy of Sciences of the United States of America 117 (22): 11875–11877. PMC 7275719. PMID 32404416. doi:10.1073/pnas.2006874117.
Velavan, T. P.; Meyer, C. G. (marzo de 2020). "The COVID-19 epidemic". Tropical Medicine & International Health n/a (n/a): 278–80. PMID 32052514. doi:10.1111/tmi.13383.
Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. (febreiro de 2020). "A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)". Military Medical Research 7 (1): 4. PMC 7003341. PMID 32029004. doi:10.1186/s40779-020-0233-6.
Chen, N.; Zhou, M.; Dong, X.; Qu, J.; Gong, F.; Han, Y.; Qiu, Y.; Wang, J.; Liu, Y.; Wei, Y.; Xia, J.; Yu, T.; Zhang, X.; Zhang, L. (de febreiro de 2020). "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study". Lancet (en English) 395 (10223): 507–513. PMID 32007143. doi:10.1016/S0140-6736(20)30211-7.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. (febreiro de 2020). "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China". Lancet 395 (10223): 497–506. PMID 31986264. doi:10.1016/S0140-6736(20)30183-5.
Lai, Chih-Cheng; Shih, Tzu-Ping; Ko, Wen-Chien; Tang, Hung-Jen; Hsueh, Po-Ren (1 de marzo de 2020). "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges". International Journal of Antimicrobial Agents (en inglés) 55 (3): 105924. ISSN 0924-8579. PMID 32081636. doi:10.1016/j.ijantimicag.2020.105924.
Zheng YY, Ma YT, Zhang JY, Xie X (marzo de 2020). "COVID-19 and the cardiovascular system". Nature Reviews. Cardiology. PMID 32139904. doi:10.1038/s41569-020-0360-5.
Douaud, Gwenaëlle; Lee, Soojin; Alfaro-Almagro, Fidel; Arthofer, Christoph; Wang, Chaoyue; McCarthy, Paul; Lange, Frederik; Andersson, Jesper L. R.; Griffanti, Ludovica (2022-03-07). "SARS-CoV-2 is associated with changes in brain structure in UK Biobank". Nature (en inglés): 1–17. ISSN 1476-4687. doi:10.1038/s41586-022-04569-5.
Lauer, Stephen A.; Grantz, Kyra H.; Bi, Qifang; Jones, Forrest K.; Zheng, Qulu; Meredith, Hannah R.; Azman, Andrew S.; Reich, Nicholas G.; Lessler, Justin (10 de marzo de 2020). "The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application". Annals of Internal Medicine (en inglés). ISSN 0003-4819. PMC 7081172. PMID 32150748. doi:10.7326/M20-0504. Arquivado dende o orixinal o 24 de marzo de 2020. Consultado o 28 de marzo de 2020.
Gorbalenya AE (11 de febreiro de 2020). "Severe acute respiratory syndrome-related coronavirus—The species and its viruses, a statement of the Coronavirus Study Group". bioRxiv (preprint). doi:10.1101/2020.02.07.937862.
Gobalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. (marzo de 2020). "The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2". Nature Microbiology: 1–9. PMID 32123347. doi:10.1038/s41564-020-0695-z. Arquivado dende o orixinal o 5 de marzo de 2020. Consultado o 3 de marzo de 2020.
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. (23 de xaneiro de 2020). "Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin". bioRxiv (preprint). doi:10.1101/2020.01.22.914952.
Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF (17 de marzo de 2020). "The proximal origin of SARS-CoV-2". Nature Medicine: 1–3. doi:10.1038/s41591-020-0820-9. Consultado o 18 de marzo de 2020.
Heymann DL, Shindo N (febreiro de 2020). "COVID-19: what is next for public health?". Lancet 395 (10224): 542–45. PMID 32061313. doi:10.1016/S0140-6736(20)30374-3.
Gehanno JF, Bonneterre V, Andujar P, Pairon J, Paris C, Petit A, et al. (30 June 2020). "How should data on airborne transmission of SARS-CoV-2 change occupational health guidelines?". Occupational and Environmental Medicine (Letter): oemed–2020–106707. PMID 32606018. doi:10.1136/oemed-2020-106707.
van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. (marzo de 2020). "Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1". The New England Journal of Medicine (Massachusetts Medical Society). PMID 32182409. doi:10.1056/nejmc2004973.
Gu, Jinyang; Han, Bing; Wang, Jian (27 de febreiro de 2020). "COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission". Gastroenterology. ISSN 0016-5085. PMID 32142785. doi:10.1053/j.gastro.2020.02.054.
Letko M, Marzi A, Munster V (2020). "Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses". Nature Microbiology 5 (4): 562–569. PMID 32094589. doi:10.1038/s41564-020-0688-y.
Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS (marzo de 2020). "Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target". Intensive Care Medicine 46 (4): 586–590. PMC 7079879. PMID 32125455. doi:10.1007/s00134-020-05985-9.
Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. (febreiro de 2020). "High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa". International Journal of Oral Science 12 (1): 8. PMC 7039956. PMID 32094336. doi:10.1038/s41368-020-0074-x.
Gurwitz D (marzo de 2020). "Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics". Drug Development Research. PMID 32129518. doi:10.1002/ddr.21656.
Hamming, I.; Timens, W.; Bulthuis, M. L. C.; Lely, A. T.; Navis, G. J.; Goor, H. van (2004). "Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis". The Journal of Pathology (en inglés) 203 (2): 631–637. ISSN 1096-9896. PMID 15141377. doi:10.1002/path.1570.
Zhang, Wei; Du, Rong-Hui; Li, Bei; Zheng, Xiao-Shuang; Yang, Xing-Lou; Hu, Ben; Wang, Yan-Yi; Xiao, Geng-Fu; Yan, Bing; Shi, Zheng-Li; Zhou, Peng (1 de xaneiro de 2020). "Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes". Emerging Microbes & Infections 9 (1): 386–389. PMC 7048229. PMID 32065057. doi:10.1080/22221751.2020.1729071.
Cohen J, Normile D (xaneiro de 2020). "New SARS-like virus in China triggers alarm" (PDF). Science 367 (6475): 234–35. Bibcode:2020Sci...367..234C. PMID 31949058. doi:10.1126/science.367.6475.234. Arquivado dende o orixinal (PDF) o 11 de febreiro de 2020. Consultado o 11 de febreiro de 2020.
Vogel, Gretchen (2020). "New blood tests for antibodies could show true scale of coronavirus pandemic". Science. ISSN 0036-8075. doi:10.1126/science.abb8028.
Pang J, Wang MX, Ang IY, Tan SH, Lewis RF, Chen JI, et al. (febreiro de 2020). "Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review". Journal of Clinical Medicine 9 (3): 623. PMID 32110875. doi:10.3390/jcm9030623.
Salehi, Sana; Abedi, Aidin; Balakrishnan, Sudheer; Gholamrezanezhad, Ali (2020-03-14). "Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients". American Journal of Roentgenology (en inglés): 1–7. ISSN 0361-803X. PMID 32174129. doi:10.2214/AJR.20.23034.
Lee, Elaine Y. P.; Ng, Ming-Yen; Khong, Pek-Lan (24 de febreiro de 2020). "COVID-19 pneumonia: what has CT taught us?". The Lancet Infectious Diseases (en English) 0 (4): 384–385. ISSN 1473-3099. PMID 32105641. doi:10.1016/S1473-3099(20)30134-1. Consultado o 13 de marzo de 2020.
Giani, Marco; Seminati, Davide; Lucchini, Alberto; Foti, Giuseppe; Pagni, Fabio (16 de marzo de 2020). "Exuberant plasmocytosis in bronchoalveolar lavage of the first patient requiring Extracorporeal Membrane Oxygenation for SARS-CoV-2 in Europe". Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer. PMID 32194247. doi:10.1016/j.jtho.2020.03.008.
Lillicrap, David (1 de abril de 2020). "Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia". Journal of thrombosis and haemostasis: JTH 18 (4): 786–787. PMID 32212240. doi:10.1111/jth.14781 – vía PubMed.
Mitra, Anupam; Dwyre, Denis M.; Schivo, Michael; Thompson, George R.; Cohen, Stuart H.; Ku, Nam; Graff, John P. (25 de marzo de 2020). "Leukoerythroblastic reaction in a patient with COVID-19 infection". American Journal of Hematology. PMID 32212392. doi:10.1002/ajh.25793 – vía PubMed.
Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD (de marzo de 2020). "How will country-based mitigation measures influence the course of the COVID-19 epidemic?". Lancet 395 (10228): 931–934. PMID 32164834. doi:10.1016/S0140-6736(20)30567-5. Un asunto clave para os epidemiólogos é axuda aos deseñadores da estratexia a decidir os principais obxectivos de mitigación, por exemplo minimizar a morbilidade e a mortalidade asociada, evitando un pico epidémico que sobrepase a capacidade dos servizos sanitarios, mantendo os efectos sobre a economía dentro de niveis manexables e aplananando a curva da epidemia en espera do desenvolvemento dunha vacina e a súa fabricación a escala e as terapias de fármacos antivirais.
Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD (marzo de 2020). "How will country-based mitigation measures influence the course of the COVID-19 epidemic?". Lancet 395 (10228): 931–934. PMID 32164834. doi:10.1016/S0140-6736(20)30567-5.
Siemieniuk, Reed AC; Bartoszko, Jessica J; Ge, Long; Zeraatkar, Dena; Izcovich, Ariel; Kum, Elena; Pardo-Hernandez, Hector; Rochwerg, Bram; Lamontagne, Francois; Han, Mi Ah; Liu, Qin; Agarwal, Arnav; Agoritsas, Thomas; Chu, Derek K; Couban, Rachel; Darzi, Andrea; Devji, Tahira; Fang, Bo; Fang, Carmen; Flottorp, Signe Agnes; Foroutan, Farid; Ghadimi, Maryam; Heels-Ansdell, Diane; Honarmand, Kimia; Hou, Liangying; Hou, Xiaorong; Ibrahim, Quazi; Khamis, Assem; Lam, Bonnie; Loeb, Mark; Marcucci, Maura; McLeod, Shelley L; Motaghi, Sharhzad; Murthy, Srinivas; Mustafa, Reem A; Neary, John D; Qasim, Anila; Rada, Gabriel; Riaz, Irbaz Bin; Sadeghirad, Behnam; Sekercioglu, Nigar; Sheng, Lulu; Sreekanta, Ashwini; Switzer, Charlotte; Tendal, Britta; Thabane, Lehana; Tomlinson, George; Turner, Tari; Vandvik, Per O; Vernooij, Robin WM; Viteri-García, Andrés; Wang, Ying; Yao, Liang; Ye, Zhikang; Guyatt, Gordon H; Brignardello-Petersen, Romina (2020-07-30). "Drug treatments for covid-19: living systematic review and network meta-analysis". BMJ (BMJ): m2980. ISSN 1756-1833. doi:10.1136/bmj.m2980.
Fisher D, Heymann D (February 2020). "Q&A: The novel coronavirus outbreak causing COVID-19". BMC Medicine 18 (1): 57. PMC 7047369. PMID 32106852. doi:10.1186/s12916-020-01533-w.
Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. (May 2020). "Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province". Chinese Medical Journal 133 (9): 1025–1031. PMC 7147277. PMID 32044814. doi:10.1097/CM9.0000000000000744.
Wang T, Du Z, Zhu F, Cao Z, An Y, Gao Y, Jiang B (March 2020). "Comorbidities and multi-organ injuries in the treatment of COVID-19". Lancet (Elsevier BV) 395 (10228): e52. PMC 7270177. PMID 32171074. doi:10.1016/s0140-6736(20)30558-4.
Wang Y, Wang Y, Chen Y, Qin Q (March 2020). "Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures". Journal of Medical Virology n/a (n/a): 568–576. PMC 7228347. PMID 32134116. doi:10.1002/jmv.25748.
Martel J, Ko YF, Young JD, Ojcius DM (May 2020). "Could nasal breathing help to mitigate the severity of COVID-19". Microbes and Infection 22 (4–5): 168–171. PMC 7200356. PMID 32387333. doi:10.1016/j.micinf.2020.05.002.
Wang L, Wang Y, Ye D, Liu Q (March 2020). "Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence". International Journal of Antimicrobial Agents 55 (6): 105948. PMC 7156162. PMID 32201353. doi:10.1016/j.ijantimicag.2020.105948. Arquivado dende o orixinal o 27 March 2020. Consultado o 27 March 2020.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. (febreiro de 2020). "Clinical Characteristics of Coronavirus Disease 2019 in China". The New England Journal of Medicine (Massachusetts Medical Society). PMID 32109013. doi:10.1056/nejmoa2002032.
Henry BM (April 2020). "COVID-19, ECMO, and lymphopenia: a word of caution". The Lancet. Respiratory Medicine (Elsevier BV) 8 (4): e24. PMC 7118650. PMID 32178774. doi:10.1016/s2213-2600(20)30119-3.
Kim, Peter S.; Read, Sarah W.; Fauci, Anthony S. (2020-12-01). "Therapy for Early COVID-19". JAMA (American Medical Association (AMA)) 324 (21): 2149. ISSN 0098-7484. doi:10.1001/jama.2020.22813.
Hsu, Jeremy (2020-11-19). "Covid-19: What now for remdesivir?". BMJ (BMJ): m4457. ISSN 1756-1833. doi:10.1136/bmj.m4457.
Cheng ZJ, Shan J (April 2020). "2019 Novel coronavirus: where we are and what we know". Infection 48 (2): 155–163. PMC 7095345. PMID 32072569. doi:10.1007/s15010-020-01401-y.
Day, Michael (17 de marzo de 2020). "Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists". BMJ 368: m1086. PMID 32184201. doi:10.1136/bmj.m1086. Consultado o 18 de marzo de 2020.
Day, Michael (17 de marzo de 2020). "Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists". BMJ (en inglés) 368: m1086. ISSN 1756-1833. PMID 32184201. doi:10.1136/bmj.m1086.
Vetter P, Eckerle I, Kaiser L (febreiro de 2020). "Covid-19: a puzzle with many missing pieces". BMJ 368: m627. PMID 32075791. doi:10.1136/bmj.m627.
Cheung JC, Ho LT, Cheng JV, Cham EY, Lam KN (febreiro de 2020). "Staff safety during emergency airway management for COVID-19 in Hong Kong". Lancet Respiratory Medicine. PMID 32105633. doi:10.1016/s2213-2600(20)30084-9.
Murthy S, Gomersall CD, Fowler RA (11 de marzo de 2020). "Care for Critically Ill Patients With COVID-19". JAMA. PMID 32159735. doi:10.1001/jama.2020.3633.
Ferguson, N.; Laydon, D.; Nedjati Gilani, G.; Imai, N.; Ainslie, K.; Baguelin, M.; Bhatia, S.; Boonyasiri, A.; Cucunuba Perez, Zulma; Cuomo-Dannenburg, G.; Dighe, A. (16 de marzo de 2020). "Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand". Imperial College London. Table 1. doi:10.25561/77482. hdl:20.1000/100.
Matthay, Michael A.; Aldrich, J. Matthew; Gotts, Jeffrey E. (marzo de 2020). "Treatment for severe acute respiratory distress syndrome from COVID-19". The Lancet Respiratory Medicine. PMID 32203709. doi:10.1016/S2213-2600(20)30127-2.
Briel, Matthias; Meade, Maureen; Mercat, Alain; Brower, Roy G.; Talmor, Daniel; Walter, Stephen D.; Slutsky, Arthur S.; Pullenayegum, Eleanor; Zhou, Qi; Cook, Deborah; Brochard, Laurent; Richard, Jean-Christophe M.; Lamontagne, Francois; Bhatnagar, Neera; Stewart, Thomas E.; Guyatt, Gordon (3 de marzo de 2010). "Higher vs Lower Positive End-Expiratory Pressure in Patients With Acute Lung Injury and Acute Respiratory Distress Syndrome". JAMA 303 (9): 865–73. PMID 20197533. doi:10.1001/jama.2010.218.
Li G, De Clercq E (marzo de 2020). "Therapeutic options for the 2019 novel coronavirus (2019-nCoV)". Nature Reviews. Drug Discovery 19 (3): 149–150. PMID 32127666. doi:10.1038/d41573-020-00016-0.
Lu H (28 de xaneiro de 2020). "Drug treatment options for the 2019-new coronavirus (2019-nCoV).". Biosci Trends 14 (1): 69–71. PMID 31996494. doi:10.5582/bst.2020.01020.
Xiang YT, Yang Y, Li W, Zhang L, Zhang Q, Cheung T, et al. (marzo de 2020). "Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed". The Lancet. Psychiatry 7 (3): 228–29. PMID 32032543. doi:10.1016/S2215-0366(20)30046-8.
Kang L, Li Y, Hu S, Chen M, Yang C, Yang BX, et al. (marzo de 2020). "The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus". The Lancet. Psychiatry 7 (3): e14. PMID 32035030. doi:10.1016/S2215-0366(20)30047-X.
Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. (18 de marzo de 2020). "SARS-CoV-2 Infection in Children". New England Journal of Medicine (Massachusetts Medical Society). ISSN 0028-4793. PMID 32187458. doi:10.1056/nejmc2005073.
Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S (2020). "Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China" (PDF). Pediatrics: e20200702. PMID 32179660. doi:10.1542/peds.2020-0702.
Fang L, Karakiulakis G, Roth M (de marzo de 2020). "Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?". The Lancet Respiratory Medicine 395 (10224): e40. PMID 32171062. doi:10.1016/S0140-6736(20)30311-1.
Heymann DL, Shindo N (febreiro de 2020). (WHO Scientific and Technical Advisory Group for Infectious Hazards), ed. "COVID-19: what is next for public health?". Lancet (Elsevier BV) 395 (10224): 542–545. PMID 32061313. doi:10.1016/s0140-6736(20)30374-3.
Douaud, Gwenaëlle; Lee, Soojin; Alfaro-Almagro, Fidel; Arthofer, Christoph; Wang, Chaoyue; McCarthy, Paul; Lange, Frederik; Andersson, Jesper L. R.; Griffanti, Ludovica (2022-03-07). "SARS-CoV-2 is associated with changes in brain structure in UK Biobank". Nature (en inglés): 1–17. ISSN 1476-4687. doi:10.1038/s41586-022-04569-5.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. (2020). "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study". The Lancet (Elsevier BV) 395 (10229): 1054–1062. ISSN 0140-6736. PMID 32171076. doi:10.1016/s0140-6736(20)30566-3.
Xu L, Liu J, Lu M, Yang D, Zheng X (maro de 2020). "Liver injury during highly pathogenic human coronavirus infections". Liver International. PMID 32170806. doi:10.1111/liv.14435.
Tian, Dai-Shi; Wang, Wei; Shang, Ke; Ma, Ke; Xie, Cuihong; Tao, Yu; Yang, Sheng; Zhang, Shuoqi; Hu, Ziwei; Zhou, Luoqi; Qin, Chuan (12 de marzo de 2020). "Dysregulation of immune response in patients with COVID-19 in Wuhan, China". Clinical Infectious Diseases. PMID 32161940. doi:10.1093/cid/ciaa248.
Wang W, Tang J, Wei F (abri de 2020). "Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China". Journal of Medical Virology 92 (4): 441–47. PMID 31994742. doi:10.1002/jmv.25689.
Ji Y, Ma Z, Peppelenbosch MP, Pan Q (febreiro 2020). "Potential association between COVID-19 mortality and health-care resource availability". Lancet Global Health 8 (4): e480. PMID 32109372. doi:10.1016/S2214-109X(20)30068-1.
Li XQ, Cai WF, Huang LF, Chen C, Liu YF, Zhang ZB, et al. (marzo de 2020). "[Comparison of epidemic characteristics between SARS in2003 and COVID-19 in 2020 in Guangzhou]". Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi (en Chinese) 41 (5): 634–637. PMID 32159317. doi:10.3760/cma.j.cn112338-20200228-00209.
Jung SM, Akhmetzhanov AR, Hayashi K, Linton NM, Yang Y, Yuan B, et al. (febreiro de 2020). "Real-Time Estimation of the Risk of Death from Novel Coronavirus (COVID-19) Infection: Inference Using Exported Cases". Journal of Clinical Medicine 9 (2): 523. PMC 7074479. PMID 32075152. doi:10.3390/jcm9020523.
Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G (marzo de 2020). "Real estimates of mortality following COVID-19 infection.". The Lancet Infectious Diseases. PMID 32171390. doi:10.1016/S1473-3099(20)30195-X.
Omer, SB; Malani, P; del Rio, C (6 April 2020). "The COVID-19 Pandemic in the US A Clinical Update". JAMA. doi:10.1001/jama.2020.5788.
Lazzerini, Marzia; Putoto, Giovanni (18 de marzo de 2020). "COVID-19 in Italy: momentous decisions and many uncertainties". The Lancet Global Health (en English) 0. ISSN 2214-109X. PMID 32199072. doi:10.1016/S2214-109X(20)30110-8.
"Virology: Coronaviruses". Nature 220 (5168): 650. 1968. Bibcode:1968Natur.220..650.. ISSN 0028-0836. doi:10.1038/220650b0.
Chen WH, Strych U, Hotez PJ, Bottazzi ME (3 de marzo de 2020). "The SARS-CoV-2 Vaccine Pipeline: an Overview". Current Tropical Medicine Reports. doi:10.1007/s40475-020-00201-6.
Ko WC, Rolain JM, Lee NY, Chen PL, Huang CT, Lee PI, Hsueh PR (marzo de 2020). "Arguments in favor of remdesivir for treating SARS-CoV-2 infections". International Journal of Antimicrobial Agents: 105933. PMID 32147516. doi:10.1016/j.ijantimicag.2020.105933.
Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. (febreiro de 2020). "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro". Cell Research 30 (3): 269–71. PMC 7054408. PMID 32020029. doi:10.1038/s41422-020-0282-0.
Gao J, Tian Z, Yang X (febreiro de 2020). "Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies". Bioscience Trends 14 (1): 72–73. PMID 32074550. doi:10.5582/bst.2020.01047.
Touret F, de Lamballerie X (marzo de 2020). "Of chloroquine and COVID-19". Antiviral Research 177: 104762. PMID 32147496. doi:10.1016/j.antiviral.2020.104762.
multicenter collaboration group of Department of Science Technology of Guangdong Province Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia (febreiro de 2020). "[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]". Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases 43: E019. PMID 32075365. doi:10.3760/cma.j.issn.1001-0939.2020.0019.
Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. (marzo de 2020). "A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19". The New England Journal of Medicine. PMID 32187464. doi:10.1056/NEJMoa2001282.
Hoffmann M, Kleine-Weber H, Krüger N, Müller M, Drosten C, Pöhlmann S (31 de xaneiro de 2020). "The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells". bioRxiv (preprint). doi:10.1101/2020.01.31.929042.
Iwata-Yoshikawa N, Okamura T, Shimizu Y, Hasegawa H, Takeda M, Nagata N (marzo de 2019). "TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection". Journal of Virology 93 (6). PMC 6401451. PMID 30626688. doi:10.1128/JVI.01815-18.
Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nature Reviews Drug Discovery 2020 Feb doi 10.1038/d41573-020-00016-0
Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, Liu X, Zhao L, Dong E, Song C, Zhan S, Lu R, Li H, Tan W, Liu D (marzo de 2020). "In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)". Clin. Infect. Dis. PMID 32150618. doi:10.1093/cid/ciaa237.
Ruan Q, Yang K, Wang W, Jiang L, Song J (marzo de 2020). "Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China". Intensive Care Medicine. PMC 7080116. PMID 32125452. doi:10.1007/s00134-020-05991-x.
Mehta P, McAuley DF, Brown M, et al. (16 marzo de 2020). "COVID-19: consider cytokine storm syndromes and immunosuppression". The Lancet 395 (10229): 1033–1034. PMID 32192578. doi:10.1016/S0140-6736(20)30628-0. Consultado o 19 de marzo de 2020.
Casadevall A, Pirofski LA (marzo de 2020). "The convalescent sera option for containing COVID-19". The Journal of Clinical Investigation. PMID 32167489. doi:10.1172/JCI138003.

ebmedicine.net

"Novel Coronavirus—COVID-19: What Emergency Clinicians Need to Know". www.ebmedicine.net. Consultado o 9 de marzo de 2020.

economist.com

"The coronavirus spreads racism against—and among—ethnic Chinese". The Economist. 17 de febreiro de 2020. Arquivado dende o orixinal o 17 de febreiro de 2020. Consultado o 17 de febreiro de 2020.

elsevier.com

Hessen MT (27 de xaneiro de 2020). "Novel Coronavirus Information Center: Expert guidance and commentary". Elsevier Connect. Arquivado dende o orixinal o 30 de xaneiro de 2020. Consultado o 31 de xaneiro de 2020.

emcrit.org

Farkas, Josh (March 2020). COVID-19—The Internet Book of Critical Care (Reference manual). USA: EMCrit. Arquivado dende o orixinal (digital) o 11 March 2020. Consultado o 13 March 2020.

entnet.org

"Anosmia, Hyposmia, and Dysgeusia Symptoms of Coronavirus Disease". American Academy of Otolaryngology-Head and neck surgery. 22 de marzo de 2020. Arquivado dende o orixinal o 24 de marzo de 2020. Consultado o 25 de marzo de 2020.

entuk.org

"Loss of sense of smell as marker of COVID-19 infection" (PDF). Arquivado dende o orixinal o 27 de maio de 2020.

err.ee

news.err.ee

Whyte, Andrew (21 de marzo de 2020). "President makes global call to combat coronavirus via hackathon". ERR (en inglés).

escardio.org

de Simone, Giovanni. "Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers". Council on Hypertension of the European Society of Cardiology. Consultado o 24 de marzo de 2020.

europa.eu

ecdc.europa.eu

"Q & A on COVID-19". European Centre for Disease Prevention and Control. Consultado o 30 de abril de 2020.
"Q & A on COVID-19". European Centre for Disease Prevention and Control (en inglés). Consultado o 23 de marzo de 2020.
"Q & A on COVID-19". European Centre for Disease Prevention and Control (en inglés). Arquivado dende o orixinal o 5 de febreiro de 2020. Consultado o 23 de marzo de 2020.
"Novel coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK – sixth update" (PDF). ecdc. Consultado o 26 de marzo de 2020.

fda.gov

"Coronavirus (COVID-19) Update: FDA Issues first Emergency Use Authorization for Point of Care Diagnostic" (Nota de prensa). FDA. 21 de marzo de 2020. Consultado o 22 de marzo de 2020.
Research, Center for Drug Evaluation and (2020-03-19). "FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19". Drug Safety and Availability (en inglés).
"Coronavirus Disease 2019 (COVID-19) Frequently Asked Questions". Food and Drug Administration.
Denise M Hinton (28 de marzo de 2020). "Request for Emergency Use Authorization For Use of Chloroquine Phosphate or Hydroxychloroquine Sulfate Supplied From the Strategic National Stockpile for Treatment of 2019 Coronavirus Disease". US Food and Drug Administration. Arquivado dende o orixinal o 30 de marzo de 2020. Consultado o 30 de marzo de 2020.
Commissioner, Office of the (29 de marzo de 2020). "Emergency Use Authorization". FDA (en inglés). Arquivado dende o orixinal o 5 de marzo de 2020. Consultado o 30 de marzo de 2020.

fiercepharma.com

"China turns Roche arthritis drug Actemra against COVID-19 in new treatment guidelines". FiercePharma. Consultado o 14 de marzo de 2020.

fundeu.es

Fundéu BBVA, ed. (29 de xaneiro de 2020). "Coronavirus, claves de escritura". Arquivado dende o orixinal o 20 de marzo de 2020. Consultado o 20 de marzo de 2020.

globenewswire.com

"Curetis Group Company Ares Genetics and BGI Group Collaborate to Offer Next-Generation Sequencing and PCR-based Coronavirus (2019-nCoV) Testing in Europe". GlobeNewswire News Room. 30 de xaneiro de 2020. Arquivado dende o orixinal o 31 de xaneiro de 2020. Consultado o 1 de febreiro de 2020.

gov.uk

"Guidance on social distancing for everyone in the UK". GOV.UK (en inglés). Consultado o 25 de marzo de 2020.

govinsider.asia

"Gov in the Time of Corona". GovInsider. 19 de marzo de 2020. Consultado o 20 de marzo de 2020.

handle.net

hdl.handle.net

Ferguson, N.; Laydon, D.; Nedjati Gilani, G.; Imai, N.; Ainslie, K.; Baguelin, M.; Bhatia, S.; Boonyasiri, A.; Cucunuba Perez, Zulma; Cuomo-Dannenburg, G.; Dighe, A. (16 de marzo de 2020). "Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand". Imperial College London. Table 1. doi:10.25561/77482. hdl:20.1000/100.

harvard.edu

adsabs.harvard.edu

Cohen J, Normile D (xaneiro de 2020). "New SARS-like virus in China triggers alarm" (PDF). Science 367 (6475): 234–35. Bibcode:2020Sci...367..234C. PMID 31949058. doi:10.1126/science.367.6475.234. Arquivado dende o orixinal (PDF) o 11 de febreiro de 2020. Consultado o 11 de febreiro de 2020.
"Virology: Coronaviruses". Nature 220 (5168): 650. 1968. Bibcode:1968Natur.220..650.. ISSN 0028-0836. doi:10.1038/220650b0.

heart.org

newsroom.heart.org

"Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician". American Heart Association (Nota de prensa). 17 de marzo de 2020. Consultado o 25 de marzo de 2020.

heise.de

Bünte, Oliver (18 de marzo de 2020). "Corona-Krise: Deutsche Telekom liefert anonymisierte Handydaten an RKI" [Corona crisis: Deutsche Telekom delivers anonymized cell phone data to RKI]. Heise Online (en alemán). Consultado o 25 de marzo de 2020.

hfsa.org

"Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician". Arquivado dende o orixinal o 21 de marzo de 2020. Consultado o 21 de marzo de 2020.

hopkinsmedicine.org

Maragakis LL. "Coronavirus, Social Distancing and Self Quarantine". www.hopkinsmedicine.org. Johns Hopkins University.
"Coronavirus recovery: breathing exercises". www.hopkinsmedicine.org. Johns Hopkins Medicine. Consultado o 30 July 2020.

ilmessaggero.it

"Coronavirus, via libera dell'Aifa al farmaco anti-artrite efficace su 3 pazienti e a un antivirale: test in 5 centri" [Coronavirus, Aifa gives go-ahead to effective anti-arthritis drug on 3 patients and an antiviral: test in 5 centers]. Il Messaggero (en italiano). Consultado o 14 de marzo de 2020.

immunology.org

"BSI open letter to Government on SARS-CoV-2 outbreak response | British Society for Immunology". www.immunology.org. Arquivado dende o orixinal o 14 de marzo de 2020. Consultado o 15 de marzo de 2020.

imperial.ac.uk

spiral.imperial.ac.uk

Ferguson, N.; Laydon, D.; Nedjati Gilani, G.; Imai, N.; Ainslie, K.; Baguelin, M.; Bhatia, S.; Boonyasiri, A.; Cucunuba Perez, Zulma; Cuomo-Dannenburg, G.; Dighe, A. (16 de marzo de 2020). "Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand". Imperial College London. Table 1. doi:10.25561/77482. hdl:20.1000/100.

independent.co.uk

"Can you get coronavirus twice or does it cause immunity?". The Independent (en inglés). 13 de marzo de 2020. Consultado o 15 de marzo de 2020.

ing.dk

"Professor: I værste fald kan Danmark med verdens største coronaudbrud i mink blive et nyt Wuhan". Berlingske Tidende. 31 October 2020. Consultado o 31 October 2020.

iss.it

epicentro.iss.it

Epidemia COVID-19. Aggiornamento nazionale 7 maggio 2020 (PDF) (Informe) (en Italian). Rome: Istituto Superiore di Sanità. 2020-05-08. Consultado o 2020-05-10.
Characteristics of COVID-19 patients dying in Italy (PDF) (Informe). Istituto Superiore di Sanità. 27 de marzo de 2020. Consultado o 27 de marzo de 2020.

jamanetwork.com

Murthy S, Gomersall CD, Fowler RA (11 de marzo de 2020). "Care for Critically Ill Patients With COVID-19". JAMA. PMID 32159735. doi:10.1001/jama.2020.3633.

jhu.edu

hub.jhu.edu

Pearce K (13 de marzo de 2020). "Antibodies from COVID-19 survivors could be used to treat patients, protect those at risk: Infusions of antibody-laden blood have been used with reported success in prior outbreaks, including the SARS epidemic and the 1918 flu pandemic". The Hub at Johns Hopkins University. Consultado o 14 de marzo de 2020.

koreabiomed.com

m.koreabiomed.com

"Physicians work out treatment guidelines for coronavirus". m.koreabiomed.com (en Korean). 13 de febreiro de 2020.

latimes.com

"They survived the coronavirus. Then they tested positive again. Why?". Los Angeles Times (en inglés). 13 de marzo de 2020. Consultado o 15 de marzo de 2020.

longislandpress.com

"Northwell Health Initiates Clinical Trials of 2 COVID-19 Drugs". 21 de marzo de 2020.

meduza.io

https://meduza.io/amp/en/feature/2020/03/21/the-ventilator-problem

merriam-webster.com

Definition of Coronavirus by Merriam-Webster. Merriam-Webster. Consultado o 24 de marzo de 2020.
Definition of Corona by Merriam-Webster. Merriam-Webster. Consultado o 24 de marzo de 2020.

mscbs.gob.es

eciemaps.mscbs.gob.es

CIE-10-es COVID-19

nap.edu

Rapid Expert Consultation on the Possibility of Bioaerosol Spread of SARS-CoV-2 for the COVID-19 Pandemic (April 1, 2020) (2020), https://www.nap.edu/catalog/25769/rapid-expert-consultation-on-the-possibility-of-bioaerosol-spread-of-sars-cov-2-for-the-covid-19-pandemic-april-1-2020

nature.com

Douaud, Gwenaëlle; Lee, Soojin; Alfaro-Almagro, Fidel; Arthofer, Christoph; Wang, Chaoyue; McCarthy, Paul; Lange, Frederik; Andersson, Jesper L. R.; Griffanti, Ludovica (2022-03-07). "SARS-CoV-2 is associated with changes in brain structure in UK Biobank". Nature (en inglés): 1–17. ISSN 1476-4687. doi:10.1038/s41586-022-04569-5.
Gobalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. (marzo de 2020). "The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2". Nature Microbiology: 1–9. PMID 32123347. doi:10.1038/s41564-020-0695-z. Arquivado dende o orixinal o 5 de marzo de 2020. Consultado o 3 de marzo de 2020.
Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF (17 de marzo de 2020). "The proximal origin of SARS-CoV-2". Nature Medicine: 1–3. doi:10.1038/s41591-020-0820-9. Consultado o 18 de marzo de 2020.
Douaud, Gwenaëlle; Lee, Soojin; Alfaro-Almagro, Fidel; Arthofer, Christoph; Wang, Chaoyue; McCarthy, Paul; Lange, Frederik; Andersson, Jesper L. R.; Griffanti, Ludovica (2022-03-07). "SARS-CoV-2 is associated with changes in brain structure in UK Biobank". Nature (en inglés): 1–17. ISSN 1476-4687. doi:10.1038/s41586-022-04569-5.

nautil.us

Berger K (12 de marzo de 2020). "The Man Who Saw the Pandemic Coming". Nautilus. Arquivado dende o orixinal o 15 de marzo de 2020. Consultado o 16 de marzo de 2020.

nejm.org

The New England Journal of Medicine. Coronavirus (Covid-19)

nhc.gov.cn

en.nhc.gov.cn

"For different groups of people: how to choose masks". NHC.gov.cn. National Health Commission of the People's Republic of China. 7 de febreiro de 2020. Arquivado dende o orixinal o 21 de outubro de 2021. Consultado o 22 de marzo de 2020. Máscaras médicas desbotables: Recomendado para: · Persoas en sitios ateigados · Ambientes de traballo a porta pechada cunha poboación relativamente densa· Persoas que acoden a institucións médicas · Nenos en garderías e estudantes en escolas que se xuntaron para estudar ou outras actividades

nhs.uk

"Self-isolation advice - Coronavirus (COVID-19)". National Health Service (United Kingdom) (en inglés). 2020-02-28. Consultado o 2020-03-27.

nice.org.uk

"Coronavirus (COVID-19) | NICE". National Institute for Health and Care Excellence. Consultado o 2021-01-18.

nih.gov

ncbi.nlm.nih.gov

Hui, D. S.; I. Azhar E.; Madani, T. A.; Ntoumi, F.; Kock, R.; Dar, O.; Ippolito, G.; Mchugh, T. D.; Memish, Z. A.; Drosten, Christian; Zumla, A.; Petersen, E. (febreiro de 2020). "The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China". Int J Infect Dis 91: 264–66. PMID 31953166. doi:10.1016/j.ijid.2020.01.009.
Stadnytskyi V, Bax CE, Bax A, Anfinrud P (xuño de 2020). "The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission". Proceedings of the National Academy of Sciences of the United States of America 117 (22): 11875–11877. PMC 7275719. PMID 32404416. doi:10.1073/pnas.2006874117.
Velavan, T. P.; Meyer, C. G. (marzo de 2020). "The COVID-19 epidemic". Tropical Medicine & International Health n/a (n/a): 278–80. PMID 32052514. doi:10.1111/tmi.13383.
Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. (febreiro de 2020). "A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)". Military Medical Research 7 (1): 4. PMC 7003341. PMID 32029004. doi:10.1186/s40779-020-0233-6.
Chen, N.; Zhou, M.; Dong, X.; Qu, J.; Gong, F.; Han, Y.; Qiu, Y.; Wang, J.; Liu, Y.; Wei, Y.; Xia, J.; Yu, T.; Zhang, X.; Zhang, L. (de febreiro de 2020). "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study". Lancet (en English) 395 (10223): 507–513. PMID 32007143. doi:10.1016/S0140-6736(20)30211-7.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. (febreiro de 2020). "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China". Lancet 395 (10223): 497–506. PMID 31986264. doi:10.1016/S0140-6736(20)30183-5.
Lai, Chih-Cheng; Shih, Tzu-Ping; Ko, Wen-Chien; Tang, Hung-Jen; Hsueh, Po-Ren (1 de marzo de 2020). "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges". International Journal of Antimicrobial Agents (en inglés) 55 (3): 105924. ISSN 0924-8579. PMID 32081636. doi:10.1016/j.ijantimicag.2020.105924.
Zheng YY, Ma YT, Zhang JY, Xie X (marzo de 2020). "COVID-19 and the cardiovascular system". Nature Reviews. Cardiology. PMID 32139904. doi:10.1038/s41569-020-0360-5.
Lauer, Stephen A.; Grantz, Kyra H.; Bi, Qifang; Jones, Forrest K.; Zheng, Qulu; Meredith, Hannah R.; Azman, Andrew S.; Reich, Nicholas G.; Lessler, Justin (10 de marzo de 2020). "The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application". Annals of Internal Medicine (en inglés). ISSN 0003-4819. PMC 7081172. PMID 32150748. doi:10.7326/M20-0504. Arquivado dende o orixinal o 24 de marzo de 2020. Consultado o 28 de marzo de 2020.
Gobalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. (marzo de 2020). "The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2". Nature Microbiology: 1–9. PMID 32123347. doi:10.1038/s41564-020-0695-z. Arquivado dende o orixinal o 5 de marzo de 2020. Consultado o 3 de marzo de 2020.
Heymann DL, Shindo N (febreiro de 2020). "COVID-19: what is next for public health?". Lancet 395 (10224): 542–45. PMID 32061313. doi:10.1016/S0140-6736(20)30374-3.
Gehanno JF, Bonneterre V, Andujar P, Pairon J, Paris C, Petit A, et al. (30 June 2020). "How should data on airborne transmission of SARS-CoV-2 change occupational health guidelines?". Occupational and Environmental Medicine (Letter): oemed–2020–106707. PMID 32606018. doi:10.1136/oemed-2020-106707.
van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. (marzo de 2020). "Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1". The New England Journal of Medicine (Massachusetts Medical Society). PMID 32182409. doi:10.1056/nejmc2004973.
Gu, Jinyang; Han, Bing; Wang, Jian (27 de febreiro de 2020). "COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission". Gastroenterology. ISSN 0016-5085. PMID 32142785. doi:10.1053/j.gastro.2020.02.054.
Letko M, Marzi A, Munster V (2020). "Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses". Nature Microbiology 5 (4): 562–569. PMID 32094589. doi:10.1038/s41564-020-0688-y.
Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS (marzo de 2020). "Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target". Intensive Care Medicine 46 (4): 586–590. PMC 7079879. PMID 32125455. doi:10.1007/s00134-020-05985-9.
Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. (febreiro de 2020). "High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa". International Journal of Oral Science 12 (1): 8. PMC 7039956. PMID 32094336. doi:10.1038/s41368-020-0074-x.
Gurwitz D (marzo de 2020). "Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics". Drug Development Research. PMID 32129518. doi:10.1002/ddr.21656.
Hamming, I.; Timens, W.; Bulthuis, M. L. C.; Lely, A. T.; Navis, G. J.; Goor, H. van (2004). "Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis". The Journal of Pathology (en inglés) 203 (2): 631–637. ISSN 1096-9896. PMID 15141377. doi:10.1002/path.1570.
Zhang, Wei; Du, Rong-Hui; Li, Bei; Zheng, Xiao-Shuang; Yang, Xing-Lou; Hu, Ben; Wang, Yan-Yi; Xiao, Geng-Fu; Yan, Bing; Shi, Zheng-Li; Zhou, Peng (1 de xaneiro de 2020). "Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes". Emerging Microbes & Infections 9 (1): 386–389. PMC 7048229. PMID 32065057. doi:10.1080/22221751.2020.1729071.
Cohen J, Normile D (xaneiro de 2020). "New SARS-like virus in China triggers alarm" (PDF). Science 367 (6475): 234–35. Bibcode:2020Sci...367..234C. PMID 31949058. doi:10.1126/science.367.6475.234. Arquivado dende o orixinal (PDF) o 11 de febreiro de 2020. Consultado o 11 de febreiro de 2020.
"Severe acute respiratory syndrome coronavirus 2 data hub". NCBI. Consultado o 4 de marzo de 2020.
Pang J, Wang MX, Ang IY, Tan SH, Lewis RF, Chen JI, et al. (febreiro de 2020). "Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review". Journal of Clinical Medicine 9 (3): 623. PMID 32110875. doi:10.3390/jcm9030623.
Salehi, Sana; Abedi, Aidin; Balakrishnan, Sudheer; Gholamrezanezhad, Ali (2020-03-14). "Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients". American Journal of Roentgenology (en inglés): 1–7. ISSN 0361-803X. PMID 32174129. doi:10.2214/AJR.20.23034.
Lee, Elaine Y. P.; Ng, Ming-Yen; Khong, Pek-Lan (24 de febreiro de 2020). "COVID-19 pneumonia: what has CT taught us?". The Lancet Infectious Diseases (en English) 0 (4): 384–385. ISSN 1473-3099. PMID 32105641. doi:10.1016/S1473-3099(20)30134-1. Consultado o 13 de marzo de 2020.
Autopsy in suspected COVID-19 cases, Hanley B et al, J Clin Pathol, PMID 32198191
Giani, Marco; Seminati, Davide; Lucchini, Alberto; Foti, Giuseppe; Pagni, Fabio (16 de marzo de 2020). "Exuberant plasmocytosis in bronchoalveolar lavage of the first patient requiring Extracorporeal Membrane Oxygenation for SARS-CoV-2 in Europe". Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer. PMID 32194247. doi:10.1016/j.jtho.2020.03.008.
Lillicrap, David (1 de abril de 2020). "Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia". Journal of thrombosis and haemostasis: JTH 18 (4): 786–787. PMID 32212240. doi:10.1111/jth.14781 – vía PubMed.
Mitra, Anupam; Dwyre, Denis M.; Schivo, Michael; Thompson, George R.; Cohen, Stuart H.; Ku, Nam; Graff, John P. (25 de marzo de 2020). "Leukoerythroblastic reaction in a patient with COVID-19 infection". American Journal of Hematology. PMID 32212392. doi:10.1002/ajh.25793 – vía PubMed.
Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD (de marzo de 2020). "How will country-based mitigation measures influence the course of the COVID-19 epidemic?". Lancet 395 (10228): 931–934. PMID 32164834. doi:10.1016/S0140-6736(20)30567-5. Un asunto clave para os epidemiólogos é axuda aos deseñadores da estratexia a decidir os principais obxectivos de mitigación, por exemplo minimizar a morbilidade e a mortalidade asociada, evitando un pico epidémico que sobrepase a capacidade dos servizos sanitarios, mantendo os efectos sobre a economía dentro de niveis manexables e aplananando a curva da epidemia en espera do desenvolvemento dunha vacina e a súa fabricación a escala e as terapias de fármacos antivirais.
Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD (marzo de 2020). "How will country-based mitigation measures influence the course of the COVID-19 epidemic?". Lancet 395 (10228): 931–934. PMID 32164834. doi:10.1016/S0140-6736(20)30567-5.
"WHO-recommended handrub formulations". WHO Guidelines on Hand Hygiene in Health Care: First Global Patient Safety Challenge Clean Care Is Safer Care. World Health Organization. 19 de marzo de2009. Consultado o 19 de marzo de 2020.
Fisher D, Heymann D (February 2020). "Q&A: The novel coronavirus outbreak causing COVID-19". BMC Medicine 18 (1): 57. PMC 7047369. PMID 32106852. doi:10.1186/s12916-020-01533-w.
Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. (May 2020). "Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province". Chinese Medical Journal 133 (9): 1025–1031. PMC 7147277. PMID 32044814. doi:10.1097/CM9.0000000000000744.
Wang T, Du Z, Zhu F, Cao Z, An Y, Gao Y, Jiang B (March 2020). "Comorbidities and multi-organ injuries in the treatment of COVID-19". Lancet (Elsevier BV) 395 (10228): e52. PMC 7270177. PMID 32171074. doi:10.1016/s0140-6736(20)30558-4.
Wang Y, Wang Y, Chen Y, Qin Q (March 2020). "Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures". Journal of Medical Virology n/a (n/a): 568–576. PMC 7228347. PMID 32134116. doi:10.1002/jmv.25748.
Martel J, Ko YF, Young JD, Ojcius DM (May 2020). "Could nasal breathing help to mitigate the severity of COVID-19". Microbes and Infection 22 (4–5): 168–171. PMC 7200356. PMID 32387333. doi:10.1016/j.micinf.2020.05.002.
Wang L, Wang Y, Ye D, Liu Q (March 2020). "Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence". International Journal of Antimicrobial Agents 55 (6): 105948. PMC 7156162. PMID 32201353. doi:10.1016/j.ijantimicag.2020.105948. Arquivado dende o orixinal o 27 March 2020. Consultado o 27 March 2020.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. (febreiro de 2020). "Clinical Characteristics of Coronavirus Disease 2019 in China". The New England Journal of Medicine (Massachusetts Medical Society). PMID 32109013. doi:10.1056/nejmoa2002032.
Henry BM (April 2020). "COVID-19, ECMO, and lymphopenia: a word of caution". The Lancet. Respiratory Medicine (Elsevier BV) 8 (4): e24. PMC 7118650. PMID 32178774. doi:10.1016/s2213-2600(20)30119-3.
Cheng ZJ, Shan J (April 2020). "2019 Novel coronavirus: where we are and what we know". Infection 48 (2): 155–163. PMC 7095345. PMID 32072569. doi:10.1007/s15010-020-01401-y.
Day, Michael (17 de marzo de 2020). "Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists". BMJ 368: m1086. PMID 32184201. doi:10.1136/bmj.m1086. Consultado o 18 de marzo de 2020.
Day, Michael (17 de marzo de 2020). "Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists". BMJ (en inglés) 368: m1086. ISSN 1756-1833. PMID 32184201. doi:10.1136/bmj.m1086.
Vetter P, Eckerle I, Kaiser L (febreiro de 2020). "Covid-19: a puzzle with many missing pieces". BMJ 368: m627. PMID 32075791. doi:10.1136/bmj.m627.
Cheung JC, Ho LT, Cheng JV, Cham EY, Lam KN (febreiro de 2020). "Staff safety during emergency airway management for COVID-19 in Hong Kong". Lancet Respiratory Medicine. PMID 32105633. doi:10.1016/s2213-2600(20)30084-9.
Murthy S, Gomersall CD, Fowler RA (11 de marzo de 2020). "Care for Critically Ill Patients With COVID-19". JAMA. PMID 32159735. doi:10.1001/jama.2020.3633.
Matthay, Michael A.; Aldrich, J. Matthew; Gotts, Jeffrey E. (marzo de 2020). "Treatment for severe acute respiratory distress syndrome from COVID-19". The Lancet Respiratory Medicine. PMID 32203709. doi:10.1016/S2213-2600(20)30127-2.
Briel, Matthias; Meade, Maureen; Mercat, Alain; Brower, Roy G.; Talmor, Daniel; Walter, Stephen D.; Slutsky, Arthur S.; Pullenayegum, Eleanor; Zhou, Qi; Cook, Deborah; Brochard, Laurent; Richard, Jean-Christophe M.; Lamontagne, Francois; Bhatnagar, Neera; Stewart, Thomas E.; Guyatt, Gordon (3 de marzo de 2010). "Higher vs Lower Positive End-Expiratory Pressure in Patients With Acute Lung Injury and Acute Respiratory Distress Syndrome". JAMA 303 (9): 865–73. PMID 20197533. doi:10.1001/jama.2010.218.
Diaz, Raiko; Heller, Daniel (2020). Barotrauma And Mechanical Ventilation. StatPearls (StatPearls Publishing). PMID 31424810.
Li G, De Clercq E (marzo de 2020). "Therapeutic options for the 2019 novel coronavirus (2019-nCoV)". Nature Reviews. Drug Discovery 19 (3): 149–150. PMID 32127666. doi:10.1038/d41573-020-00016-0.
Lu H (28 de xaneiro de 2020). "Drug treatment options for the 2019-new coronavirus (2019-nCoV).". Biosci Trends 14 (1): 69–71. PMID 31996494. doi:10.5582/bst.2020.01020.
Xiang YT, Yang Y, Li W, Zhang L, Zhang Q, Cheung T, et al. (marzo de 2020). "Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed". The Lancet. Psychiatry 7 (3): 228–29. PMID 32032543. doi:10.1016/S2215-0366(20)30046-8.
Kang L, Li Y, Hu S, Chen M, Yang C, Yang BX, et al. (marzo de 2020). "The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus". The Lancet. Psychiatry 7 (3): e14. PMID 32035030. doi:10.1016/S2215-0366(20)30047-X.
Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. (18 de marzo de 2020). "SARS-CoV-2 Infection in Children". New England Journal of Medicine (Massachusetts Medical Society). ISSN 0028-4793. PMID 32187458. doi:10.1056/nejmc2005073.
Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S (2020). "Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China" (PDF). Pediatrics: e20200702. PMID 32179660. doi:10.1542/peds.2020-0702.
Fang L, Karakiulakis G, Roth M (de marzo de 2020). "Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?". The Lancet Respiratory Medicine 395 (10224): e40. PMID 32171062. doi:10.1016/S0140-6736(20)30311-1.
Heymann DL, Shindo N (febreiro de 2020). (WHO Scientific and Technical Advisory Group for Infectious Hazards), ed. "COVID-19: what is next for public health?". Lancet (Elsevier BV) 395 (10224): 542–545. PMID 32061313. doi:10.1016/s0140-6736(20)30374-3.
Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R (2020). "Features, Evaluation and Treatment Coronavirus (COVID-19)". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 32150360. Consultado o 18 demarzo de 2020.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. (2020). "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study". The Lancet (Elsevier BV) 395 (10229): 1054–1062. ISSN 0140-6736. PMID 32171076. doi:10.1016/s0140-6736(20)30566-3.
Xu L, Liu J, Lu M, Yang D, Zheng X (maro de 2020). "Liver injury during highly pathogenic human coronavirus infections". Liver International. PMID 32170806. doi:10.1111/liv.14435.
Tian, Dai-Shi; Wang, Wei; Shang, Ke; Ma, Ke; Xie, Cuihong; Tao, Yu; Yang, Sheng; Zhang, Shuoqi; Hu, Ziwei; Zhou, Luoqi; Qin, Chuan (12 de marzo de 2020). "Dysregulation of immune response in patients with COVID-19 in Wuhan, China". Clinical Infectious Diseases. PMID 32161940. doi:10.1093/cid/ciaa248.
Wang W, Tang J, Wei F (abri de 2020). "Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China". Journal of Medical Virology 92 (4): 441–47. PMID 31994742. doi:10.1002/jmv.25689.
Ji Y, Ma Z, Peppelenbosch MP, Pan Q (febreiro 2020). "Potential association between COVID-19 mortality and health-care resource availability". Lancet Global Health 8 (4): e480. PMID 32109372. doi:10.1016/S2214-109X(20)30068-1.
Li XQ, Cai WF, Huang LF, Chen C, Liu YF, Zhang ZB, et al. (marzo de 2020). "[Comparison of epidemic characteristics between SARS in2003 and COVID-19 in 2020 in Guangzhou]". Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi (en Chinese) 41 (5): 634–637. PMID 32159317. doi:10.3760/cma.j.cn112338-20200228-00209.
Jung SM, Akhmetzhanov AR, Hayashi K, Linton NM, Yang Y, Yuan B, et al. (febreiro de 2020). "Real-Time Estimation of the Risk of Death from Novel Coronavirus (COVID-19) Infection: Inference Using Exported Cases". Journal of Clinical Medicine 9 (2): 523. PMC 7074479. PMID 32075152. doi:10.3390/jcm9020523.
Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G (marzo de 2020). "Real estimates of mortality following COVID-19 infection.". The Lancet Infectious Diseases. PMID 32171390. doi:10.1016/S1473-3099(20)30195-X.
Lazzerini, Marzia; Putoto, Giovanni (18 de marzo de 2020). "COVID-19 in Italy: momentous decisions and many uncertainties". The Lancet Global Health (en English) 0. ISSN 2214-109X. PMID 32199072. doi:10.1016/S2214-109X(20)30110-8.
Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R (marzo de 2020). "Features, Evaluation and Treatment Coronavirus (COVID-19)". StatPearls [Internet]. PMID 32150360. Bookshelf ID: NBK554776.
Ko WC, Rolain JM, Lee NY, Chen PL, Huang CT, Lee PI, Hsueh PR (marzo de 2020). "Arguments in favor of remdesivir for treating SARS-CoV-2 infections". International Journal of Antimicrobial Agents: 105933. PMID 32147516. doi:10.1016/j.ijantimicag.2020.105933.
Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. (febreiro de 2020). "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro". Cell Research 30 (3): 269–71. PMC 7054408. PMID 32020029. doi:10.1038/s41422-020-0282-0.
Gao J, Tian Z, Yang X (febreiro de 2020). "Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies". Bioscience Trends 14 (1): 72–73. PMID 32074550. doi:10.5582/bst.2020.01047.
Touret F, de Lamballerie X (marzo de 2020). "Of chloroquine and COVID-19". Antiviral Research 177: 104762. PMID 32147496. doi:10.1016/j.antiviral.2020.104762.
multicenter collaboration group of Department of Science Technology of Guangdong Province Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia (febreiro de 2020). "[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]". Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases 43: E019. PMID 32075365. doi:10.3760/cma.j.issn.1001-0939.2020.0019.
Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. (marzo de 2020). "A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19". The New England Journal of Medicine. PMID 32187464. doi:10.1056/NEJMoa2001282.
Iwata-Yoshikawa N, Okamura T, Shimizu Y, Hasegawa H, Takeda M, Nagata N (marzo de 2019). "TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection". Journal of Virology 93 (6). PMC 6401451. PMID 30626688. doi:10.1128/JVI.01815-18.
Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, Liu X, Zhao L, Dong E, Song C, Zhan S, Lu R, Li H, Tan W, Liu D (marzo de 2020). "In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)". Clin. Infect. Dis. PMID 32150618. doi:10.1093/cid/ciaa237.
Ruan Q, Yang K, Wang W, Jiang L, Song J (marzo de 2020). "Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China". Intensive Care Medicine. PMC 7080116. PMID 32125452. doi:10.1007/s00134-020-05991-x.
Mehta P, McAuley DF, Brown M, et al. (16 marzo de 2020). "COVID-19: consider cytokine storm syndromes and immunosuppression". The Lancet 395 (10229): 1033–1034. PMID 32192578. doi:10.1016/S0140-6736(20)30628-0. Consultado o 19 de marzo de 2020.
Casadevall A, Pirofski LA (marzo de 2020). "The convalescent sera option for containing COVID-19". The Journal of Clinical Investigation. PMID 32167489. doi:10.1172/JCI138003.

covid19treatmentguidelines.nih.gov

"COVID-19 Treatment Guidelines". www.nih.gov. National Institutes of Health. Arquivado dende o orixinal o 19 de xaneiro de 2021. Consultado o 2021-01-18.
"COVID-19 Treatment Guidelines". www.nih.gov. National Institutes of Health. Arquivado dende o orixinal o 19 de xaneiro de 2021. Consultado o 2021-01-18. /

nih.gov

"New coronavirus stable for hours on surfaces". National Institutes of Health. 17 de marzo de 2020. Consultado o 23 de marzo de 2020.

npr.org

"My Hand-Washing Song: Readers Offer Lyrics For A 20-Second Scrub". NPR.org (en inglés). Consultado o 20 de marzo de 2020.

nytimes.com

Parker-Pope, Tara (19 de marzo de 2020). "Deciding How Much Distance You Should Keep". The New York Times (en inglés). ISSN 0362-4331. Consultado o 20 de marzo de 2020.
Goldstein, Joseph (6 de abril de 2020). "Bronx Zoo Tiger Is Sick With the Coronavirus". The New York Times. Consultado o 9 de abril de 2020.

ourworldindata.org

Roser M, Ritchie H, Ortiz-Ospina E (4 de marzo de 2020). "Coronavirus Disease (COVID-19)". Our World in Data. Consultado o 12 de marzo de 2020.
Ritchie, Hannah; Roser, Max (25 de marzo de 2020). Chivers, Tom, ed. "What do we know about the risk of dying from COVID-19?". Our World in Data. Consultado o 28 de marzo de 2020.
"What do we know about the risk of dying from COVID-19?". Our World in Data. Consultado o 28 de marzo de 2020.
"Total confirmed cases of COVID-19 per million people". Our World in Data. Consultado o 20 de marzo de 2020.
"Total confirmed deaths due to COVID-19 per million people". Our World in Data. Consultado o 24 de marzo de 2020.

politico.eu

Manancourt, Vincent (10 de marzo de 2020). "Coronavirus tests Europe's resolve on privacy". POLITICO. Consultado o 20 de marzo de 2020.

portaldaspalabras.gal

Portal das Palabras Allos con bugallos. COVID-19?
Definicións no Dicionario da Real Academia Galega e no Portal das Palabras para covid-19.
Definicións no Dicionario da Real Academia Galega e no Portal das Palabras para sida.

post-gazette.com

"Italians scolded for flouting lockdown as death toll nears 3,000". Pittsburgh Post-Gazette (en inglés). Consultado o 20 de marzo de 2020.

reuters.com

Kuhakan, Jiraporn (12 de marzo de 2020). "'Better than nothing': Thailand encourages cloth masks amid surgical mask shortage". Reuters. As autoridades sanitarias de Tailandia animan á xente a fabricar máscaras faciais de tea en casa para protexerse contra o espallamento do coronavirus dada a escaseza de máscaras quirúrxicas. ... As pingas procedentes de toses e espirros son duns cinco microns e xa comprobamos que as máscaras de tea poden protexer contra pingas maiores dun micron.
"Chinese doctors using plasma therapy on coronavirus, WHO says 'very valid' approach". Reuters. 17 de febreiro de 2020 – vía www.reuters.com.
Steenhuysen J, Kelland K (24 de xaneiro de 2020). "With Wuhan virus genetic code in hand, scientists begin work on a vaccine". Reuters. Arquivado dende o orixinal o 25 de xaneiro de 2020. Consultado o 25 de xaneiro de 2020.
Nebehay S, Kelland K, Liu R (5 de febreiro de 2020). "WHO: 'no known effective' treatments for new coronavirus". Thomson Reuters. Arquivado dende o orixinal o 5 de febreiro de 2020. Consultado o 5 de febreiro de 2020.
"Moscow deploys facial recognition technology for coronavirus quarantine". Reuters (en inglés). 21 de febreiro de 2020. Consultado o 20 de marzo de 2020.
BRIEF-Corrected-Zhejiang Hisun Pharma gets approval for clinical trial to test flu drug Favipiravir for pneumonia caused by new coronavirus. Reuters Healthcare, 16 de febreiro de 2020.
Liu R, Miller J (3 de marzo de 2020). "China approves use of Roche drug in battle against coronavirus complications". Reuters. Consultado o 14 de marzo de 2020.

sciencealert.com

Grenfell R, Drew T (17 de febreiro de 2020). "Here's Why It's Taking So Long to Develop a Vaccine for the New Coronavirus". Science Alert. Arquivado dende o orixinal o 28 de febreiro de 2020. Consultado o 26 de febreiro de 2020.
AFP (19 de marzo de 2020). "Updated: WHO Now Doesn't Recommend Avoiding Ibuprofen For COVID-19 Symptoms". ScienceAlert. Consultado o 19 de marzo de 2020.

sciencedaily.com

"CT provides best diagnosis for COVID-19". ScienceDaily. 26 de febreiro de 2020. Consultado o 2 de marzo de 2020.

sciencedirect.com

Wang L, Wang Y, Ye D, Liu Q (March 2020). "Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence". International Journal of Antimicrobial Agents 55 (6): 105948. PMC 7156162. PMID 32201353. doi:10.1016/j.ijantimicag.2020.105948. Arquivado dende o orixinal o 27 March 2020. Consultado o 27 March 2020.

sciencemag.org

"COVID-19 hits U.S. mink farms after ripping through Europe". ScienceMag.org. 18 August 2020. Consultado o 31 October 2020.
Kupferschmidt, Kai; Cohen, Jon (22 de marzo de 2020). "WHO launches global megatrial of the four most promising coronavirus treatments". Science | AAAS (en inglés). Consultado o 23 de mazo de 2020.

science.sciencemag.org

Shi, Jianzhong; Wen, Zhiyuan; Zhong, Gongxun (8 de abril de 2020). "Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2". Science. Consultado o 9 de abril de 2020.

scmp.com

Cheung E (13 de marzo de 2020). "Some recovered Covid-19 patients may have lung damage, doctors say". South China Morning Post (en inglés).

sergas.gal

SERGAS Enfermidade polo novo coronavirus (COVID-19)

ssrn.com

Wei, Xiao-Shan; Wang, Xuan; Niu, Yi-Ran; Ye, Lin-Lin; Peng, Wen-Bei; Wang, Zi-Hao; Yang, Wei-Bing; Yang, Bo-Han; Zhang, Jian-Chu; Ma, Wan-Li; Wang, Xiao-Rong (26 de febreiro de 2020). Clinical Characteristics of SARS-CoV-2 Infected Pneumonia with Diarrhea (en inglés). Rochester, NY. SSRN 3546120.

symmetrymagazine.org

Biron, Lauren. "Physics community designs simplified ventilator". symmetry magazine (en inglés). Consultado o 2020-05-10.

technologyreview.com

Chen A. "China's coronavirus app could have unintended consequences". MIT Technology Review. Consultado o 7 de marzo de 2020.

theguardian.com

Davidson, Helen (13 de marzo de 2020). "First Covid-19 case happened in November, China government records show—report". The Guardian. Consultado o 21 de marzo de 2020.

thelancet.com

Lee, Elaine Y. P.; Ng, Ming-Yen; Khong, Pek-Lan (24 de febreiro de 2020). "COVID-19 pneumonia: what has CT taught us?". The Lancet Infectious Diseases (en English) 0 (4): 384–385. ISSN 1473-3099. PMID 32105641. doi:10.1016/S1473-3099(20)30134-1. Consultado o 13 de marzo de 2020.
Lazzerini, Marzia; Putoto, Giovanni (18 de marzo de 2020). "COVID-19 in Italy: momentous decisions and many uncertainties". The Lancet Global Health (en English) 0. ISSN 2214-109X. PMID 32199072. doi:10.1016/S2214-109X(20)30110-8.
Mehta P, McAuley DF, Brown M, et al. (16 marzo de 2020). "COVID-19: consider cytokine storm syndromes and immunosuppression". The Lancet 395 (10229): 1033–1034. PMID 32192578. doi:10.1016/S0140-6736(20)30628-0. Consultado o 19 de marzo de 2020.

thespinoff.co.nz

Wiles S (9 de marzo de 2020). "The three phases of Covid-19 – and how we can make it manageable". The Spinoff. Consultado o 9 de marzo de 2020.
Wiles, Siouxsie (14 de marzo de 2020). "After 'Flatten the Curve', we must now 'Stop the Spread'. Here's what that means". The Spinoff. Consultado o 13 de marzo de 2020.

todayonline.com

"Novel coronavirus named 'Covid-19': WHO". TODAYonline. Consultado o 11 de febreiro de 2020.

uconn.edu

mcb.uconn.edu

Cohen J, Normile D (xaneiro de 2020). "New SARS-like virus in China triggers alarm" (PDF). Science 367 (6475): 234–35. Bibcode:2020Sci...367..234C. PMID 31949058. doi:10.1126/science.367.6475.234. Arquivado dende o orixinal (PDF) o 11 de febreiro de 2020. Consultado o 11 de febreiro de 2020.

un.org

news.un.org

"UN health chief announces global 'solidarity trial' to jumpstart search for COVID-19 treatment". UN News (en inglés). 18 de marzo de 2020. Consultado o 23 de marzo de 2020.

upenn.edu

guides.library.upenn.edu

"COVID19—Resources for Health Care Professionals". Penn Libraries. 11 March 2020. Arquivado dende o orixinal o 14 March 2020. Consultado o 13 March 2020.

vox.com

Barclay E (10 de marzo de 2020). "How canceled events and self-quarantines save lives, in one chart". Vox.
Barclay E, Scott D, Animashaun A (7 April 2020). "The US doesn't just need to flatten the curve. It needs to "raise the line."". Vox. Arquivado dende o orixinal o 7 April 2020.
Scott, Dylan (16 de marzo de 2020). "Coronavirus is exposing all of the weaknesses in the US health system High health care costs and low medical capacity made the US uniquely vulnerable to the coronavirus.". Vox. Consultado o 18 de marzo de 2020.
"How doctors can potentially significantly reduce the number of deaths from Covid-19". Vox. 12 de marzo de 2020. Consultado o 14 de marzo de 2020.

washingtonpost.com

Mahtani, S.; Berger, M.; O'Grady, S.; Iati, M. (6 de febreiro de 2020). "Hundreds of evacuees to be held on bases in California; Hong Kong and Taiwan restrict travel from mainland China". The Washington Post. Arquivado dende o orixinal o 7 de febreiro de 2020. Consultado o 11 de febreiro de 2020.

web.archive.org

"Coronavirus Disease 2019 (COVID-19) Symptoms". Centers for Disease Control and Prevention. United States. 10 de febreiro de 2020. Arquivado dende o orixinal o 30 de xaneiro de 2020.
"Naming the coronavirus disease (COVID-19) and the virus that causes it". World Health Organization (WHO). Arquivado dende o orixinal o 28 de febreiro de 2020. Consultado o 28 de febreiro de 2020.
"Anosmia, Hyposmia, and Dysgeusia Symptoms of Coronavirus Disease". American Academy of Otolaryngology-Head and neck surgery. 22 de marzo de 2020. Arquivado dende o orixinal o 24 de marzo de 2020. Consultado o 25 de marzo de 2020.
"Q&A on coronaviruses". World Health Organization (WHO). Arquivado dende o orixinal o 20 de xaneiro de 2020. Consultado o 27 de xaneiro de 2020.
"Q&A on coronaviruses (COVID-19)". World Health Organization. 17 de abril de 2020. Arquivado dende o orixinal o 14 de maio de 2020. Consultado o 14 de maio de 2020.
"How COVID-19 Spreads". U.S. Centers for Disease Control and Prevention (CDC). 2 de abril de 2020. Arquivado dende o orixinal o 3 de abril de 2020. Consultado o 3 de abril de 2020.
"Symptoms of Novel Coronavirus (2019-nCoV)". www.cdc.gov. 10 de febreiro de 2020. Arquivado dende o orixinal o 30 de xaneiro de 2020. Consultado o 11 de febreiro de 2020.
"Advice for public". World Health Organization (WHO). Arquivado dende o orixinal o 26 de xaneiro de 2020. Consultado o 25 de febreiro de 2020.
CDC (11 de febreiro de 2020). "2019 Novel Coronavirus (2019-nCoV)". Centers for Disease Control and Prevention. Arquivado dende o orixinal o 14 de febreiro de 2020. Consultado o 15 de febreiro de 2020.
"Advice for public". World Health Organization (WHO). Arquivado dende o orixinal o 26 de xaneiro de 2020. Consultado o 15 de febreiro de 2020.
"Coronavirus Disease 2019 (COVID-19)". Centers for Disease Control and Prevention (CDC). 15 de febreiro de 2020. Arquivado dende o orixinal o 26 de febreiro de 2020. Consultado o 20 de febreiro de 2020.
"Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)". World Health Organization (WHO). Arquivado dende o orixinal o 31 de xaneiro de 2020. Consultado o 11 de febreiro de 2020.
Mahtani, S.; Berger, M.; O'Grady, S.; Iati, M. (6 de febreiro de 2020). "Hundreds of evacuees to be held on bases in California; Hong Kong and Taiwan restrict travel from mainland China". The Washington Post. Arquivado dende o orixinal o 7 de febreiro de 2020. Consultado o 11 de febreiro de 2020.
"Loss of sense of smell as marker of COVID-19 infection" (PDF). Arquivado dende o orixinal o 27 de maio de 2020.
Hessen MT (27 de xaneiro de 2020). "Novel Coronavirus Information Center: Expert guidance and commentary". Elsevier Connect. Arquivado dende o orixinal o 30 de xaneiro de 2020. Consultado o 31 de xaneiro de 2020.
"Q&A on coronaviruses (COVID-19): How long is the incubation period for COVID-19?". World Health Organization (WHO). Arquivado dende o orixinal o 20 e xaneiro de 2020. Consultado o 26 de febreiro de 2020.
Lauer, Stephen A.; Grantz, Kyra H.; Bi, Qifang; Jones, Forrest K.; Zheng, Qulu; Meredith, Hannah R.; Azman, Andrew S.; Reich, Nicholas G.; Lessler, Justin (10 de marzo de 2020). "The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application". Annals of Internal Medicine (en inglés). ISSN 0003-4819. PMC 7081172. PMID 32150748. doi:10.7326/M20-0504. Arquivado dende o orixinal o 24 de marzo de 2020. Consultado o 28 de marzo de 2020.
Gobalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. (marzo de 2020). "The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2". Nature Microbiology: 1–9. PMID 32123347. doi:10.1038/s41564-020-0695-z. Arquivado dende o orixinal o 5 de marzo de 2020. Consultado o 3 de marzo de 2020.
Berger K (12 de marzo de 2020). "The Man Who Saw the Pandemic Coming". Nautilus. Arquivado dende o orixinal o 15 de marzo de 2020. Consultado o 16 de marzo de 2020.
"2019 Novel Coronavirus (2019-nCoV)". Centers for Disease Control and Prevention. 11 de febreiro de 2020. Arquivado dende o orixinal o 7 de marzo de 2020. Consultado o 18 de febreiro de 2020. O virus pénsase que se espalla principalmente de persoa a persoa ... por medio das pinguiñas respiratorias producidas cando unha persoa infectada tose ou espirra.
"Q & A on COVID-19". European Centre for Disease Prevention and Control (en inglés). Arquivado dende o orixinal o 5 de febreiro de 2020. Consultado o 23 de marzo de 2020.
CDC (5 de febreiro de 2020). "CDC Tests for 2019-nCoV". Centers for Disease Control and Prevention. Arquivado dende o orixinal o 14 de febreiro de 2020. Consultado o 12 de febreiro de 2020.
"2019 Novel Coronavirus (2019-nCoV) Situation Summary". Centers for Disease Control and Prevention. 30 de xaneiro de 2020. Arquivado dende o orixinal o 26 de xaneiro de 2020. Consultado o 30 de xaneiro de 2020.
"Real-Time RT-PCR Panel for Detection 2019-nCoV". Centers for Disease Control and Prevention. 29 de xaneiro de 2020. Arquivado dende o orixinal o 30 de xaneiro de 2020. Consultado o 1 de febreiro de 2020.
"Curetis Group Company Ares Genetics and BGI Group Collaborate to Offer Next-Generation Sequencing and PCR-based Coronavirus (2019-nCoV) Testing in Europe". GlobeNewswire News Room. 30 de xaneiro de 2020. Arquivado dende o orixinal o 31 de xaneiro de 2020. Consultado o 1 de febreiro de 2020.
Brueck H (30 de xaneiro de 2020). "There's only one way to know if you have the coronavirus, and it involves machines full of spit and mucus". Business Insider. Arquivado dende o orixinal o 1 de febreiro de 2020. Consultado o 1 de febreiro de 2020.
"Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases". Arquivado dende o orixinal o 21 de febreiro de 2020. Consultado o 26 de febreiro de 2020.
Cohen J, Normile D (xaneiro de 2020). "New SARS-like virus in China triggers alarm" (PDF). Science 367 (6475): 234–35. Bibcode:2020Sci...367..234C. PMID 31949058. doi:10.1126/science.367.6475.234. Arquivado dende o orixinal (PDF) o 11 de febreiro de 2020. Consultado o 11 de febreiro de 2020.
Barclay E, Scott D, Animashaun A (7 April 2020). "The US doesn't just need to flatten the curve. It needs to "raise the line."". Vox. Arquivado dende o orixinal o 7 April 2020.
Centers for Disease Control (3 de febreiro de 2020). "Coronavirus Disease 2019 (COVID-19): Prevention & Treatment" (en inglés). Arquivado dende o orixinal o 15 de decembro de 2019. Consultado o 10 de febreiro de 2020.
World Health Organization. "Advice for Public". Arquivado dende o orixinal o 26 de xaneiro de 2020. Consultado o 10 de febreiro de 2020.
Grenfell R, Drew T (17 de febreiro de 2020). "Here's Why It's Taking So Long to Develop a Vaccine for the New Coronavirus". Science Alert. Arquivado dende o orixinal o 28 de febreiro de 2020. Consultado o 26 de febreiro de 2020.
"For different groups of people: how to choose masks". NHC.gov.cn. National Health Commission of the People's Republic of China. 7 de febreiro de 2020. Arquivado dende o orixinal o 21 de outubro de 2021. Consultado o 22 de marzo de 2020. Máscaras médicas desbotables: Recomendado para: · Persoas en sitios ateigados · Ambientes de traballo a porta pechada cunha poboación relativamente densa· Persoas que acoden a institucións médicas · Nenos en garderías e estudantes en escolas que se xuntaron para estudar ou outras actividades
"Prevention of Coronavirus Disease 2019 (COVID-19)" (PDF). Centre for Health Protection. Arquivado dende o orixinal (PDF) o 21 de marzo de 2020. Consultado o 22 de marzo de 2020. O uso de máscaras quirúrxicas cando se usa o transporte público ou en sitios ateigados.
Centers for Disease Control and Prevention (11 de febreiro de 2020). "What to do if you are sick with 2019 Novel Coronavirus (2019-nCoV)" (en inglés). Arquivado dende o orixinal o 14 de febreiro de 2020. Consultado o 13 de febreiro de 2020.
"Coronavirus". WebMD. Arquivado dende o orixinal o 2020-02-01. Consultado o 2020-02-01.
Wang L, Wang Y, Ye D, Liu Q (March 2020). "Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence". International Journal of Antimicrobial Agents 55 (6): 105948. PMC 7156162. PMID 32201353. doi:10.1016/j.ijantimicag.2020.105948. Arquivado dende o orixinal o 27 March 2020. Consultado o 27 March 2020.
U.S. Centers for Disease Control and Prevention (5 de abril de 2020). "What to Do if You Are Sick". Centers for Disease Control and Prevention (CDC). Arquivado dende o orixinal o 14 de febreiro de 2020. Consultado o 24 de abril de 2020.
"Home". National COVID-19 Clinical Evidence Taskforce (en inglés). Arquivado dende o orixinal o 11 de outubro de 2020. Consultado o 2020-07-11.
"COVID-19 Treatment Guidelines". www.nih.gov. National Institutes of Health. Arquivado dende o orixinal o 19 de xaneiro de 2021. Consultado o 2021-01-18.
"COVID-19 Treatment Guidelines". www.nih.gov. National Institutes of Health. Arquivado dende o orixinal o 19 de xaneiro de 2021. Consultado o 2021-01-18. /
Farkas, Josh (March 2020). COVID-19—The Internet Book of Critical Care (Reference manual). USA: EMCrit. Arquivado dende o orixinal (digital) o 11 March 2020. Consultado o 13 March 2020.
"COVID19—Resources for Health Care Professionals". Penn Libraries. 11 March 2020. Arquivado dende o orixinal o 14 March 2020. Consultado o 13 March 2020.
"Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician". Arquivado dende o orixinal o 21 de marzo de 2020. Consultado o 21 de marzo de 2020.
Steenhuysen J, Kelland K (24 de xaneiro de 2020). "With Wuhan virus genetic code in hand, scientists begin work on a vaccine". Reuters. Arquivado dende o orixinal o 25 de xaneiro de 2020. Consultado o 25 de xaneiro de 2020.
Duddu P (19 de febreiro de 2020). "Coronavirus outbreak: Vaccines/drugs in the pipeline for Covid-19". clinicaltrialsarena.com. Arquivado dende o orixinal o 19 de febreiro de 2020.
Nebehay S, Kelland K, Liu R (5 de febreiro de 2020). "WHO: 'no known effective' treatments for new coronavirus". Thomson Reuters. Arquivado dende o orixinal o 5 de febreiro de 2020. Consultado o 5 de febreiro de 2020.
"Kreative Lösungen gesucht". Startseite (en alemán). Arquivado dende o orixinal o 24 de marzo de 2020. Consultado o 28 de marzo de 2020.
"Coronavirus Age, Sex, Demographics (COVID-19)". www.worldometers.info. Arquivado dende o orixinal o 27 de febreiro de 2020. Consultado o 26 de febreiro de 2020.
"BSI open letter to Government on SARS-CoV-2 outbreak response | British Society for Immunology". www.immunology.org. Arquivado dende o orixinal o 14 de marzo de 2020. Consultado o 15 de marzo de 2020.
"The coronavirus spreads racism against—and among—ethnic Chinese". The Economist. 17 de febreiro de 2020. Arquivado dende o orixinal o 17 de febreiro de 2020. Consultado o 17 de febreiro de 2020.
Fundéu - BBVA coronavirus
Fundéu BBVA, ed. (29 de xaneiro de 2020). "Coronavirus, claves de escritura". Arquivado dende o orixinal o 20 de marzo de 2020. Consultado o 20 de marzo de 2020.
Denise M Hinton (28 de marzo de 2020). "Request for Emergency Use Authorization For Use of Chloroquine Phosphate or Hydroxychloroquine Sulfate Supplied From the Strategic National Stockpile for Treatment of 2019 Coronavirus Disease". US Food and Drug Administration. Arquivado dende o orixinal o 30 de marzo de 2020. Consultado o 30 de marzo de 2020.
Commissioner, Office of the (29 de marzo de 2020). "Emergency Use Authorization". FDA (en inglés). Arquivado dende o orixinal o 5 de marzo de 2020. Consultado o 30 de marzo de 2020.

webmd.com

"Coronavirus". WebMD. Arquivado dende o orixinal o 2020-02-01. Consultado o 2020-02-01.

who.int

"Naming the coronavirus disease (COVID-19) and the virus that causes it". World Health Organization (WHO). Arquivado dende o orixinal o 28 de febreiro de 2020. Consultado o 28 de febreiro de 2020.
"WHO Director-General's opening remarks at the media briefing on COVID-19". World Health Organization (WHO) (Nota de prensa). 11 de marzo de 2020. Consultado o 12 de marzo de 2020.
"Q&A on coronaviruses (COVID-19)". World Health Organization (WHO). Consultado o 11 de marzo de 2020.
"Q&A on coronaviruses". World Health Organization (WHO). Arquivado dende o orixinal o 20 de xaneiro de 2020. Consultado o 27 de xaneiro de 2020.
"Q&A on coronaviruses (COVID-19)". World Health Organization. 17 de abril de 2020. Arquivado dende o orixinal o 14 de maio de 2020. Consultado o 14 de maio de 2020.
"Q&A: How is COVID-19 transmitted?". www.who.int (en inglés). Consultado o 12 de xullo de 2020.
"Advice for public". World Health Organization (WHO). Arquivado dende o orixinal o 26 de xaneiro de 2020. Consultado o 25 de febreiro de 2020.
"Advice for public". World Health Organization (WHO). Arquivado dende o orixinal o 26 de xaneiro de 2020. Consultado o 15 de febreiro de 2020.
"Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)". World Health Organization (WHO). Arquivado dende o orixinal o 31 de xaneiro de 2020. Consultado o 11 de febreiro de 2020.
"WHO Situation Report #65" (PDF). WHO. 25 de marzo de 2020.
Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) (PDF) (Informe). World Health Organization (WHO). 16-24 de febreiro de 2020. Consultado o 21 de marzo de 2020.
"Q&A on coronaviruses (COVID-19): How long is the incubation period for COVID-19?". World Health Organization (WHO). Arquivado dende o orixinal o 20 e xaneiro de 2020. Consultado o 26 de febreiro de 2020.
"Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations". www.who.int (en inglés). Consultado o 29 de marzo de 2020.
"Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases". World Health Organization (WHO). Consultado o 13 de marzo de 2020.
"Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases". Arquivado dende o orixinal o 21 de febreiro de 2020. Consultado o 26 de febreiro de 2020.
World Health Organization. "Advice for Public". Arquivado dende o orixinal o 26 de xaneiro de 2020. Consultado o 10 de febreiro de 2020.
"When and how to use masks". World Health Organization (WHO). Consultado o 8 de marzo de 2020.
"Shortage of personal protective equipment endangering health workers worldwide" (Nota de prensa). WHO. 3 de marzo de 2020. Consultado o 24 de marzo de 2020.
"Q&A: Dexamethasone and COVID-19". www.who.int (en inglés). Consultado o 2020-07-11.
"Clinical management of COVID-19". World Health Organization (WHO). 2020-05-27. Consultado o 2021-01-18.
World Health Organization (28 de xaneiro de 2020). "Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected" (PDF).
"WHO Director-General's statement on the advice of the IHR Emergency Committee on Novel Coronavirus". World Health Organization (WHO).
"Coronavirus disease 2019: Situation Report 69" (PDF). World Health Organization. 29 de marzo de 2020. Consultado o 29 de marzo de 2020.
"Naming the coronavirus disease (COVID-19) and the virus that causes it". World Health Organization (WHO). Consultado o 13 de marzo de 2020.
"Novel Coronavirus(2019-nCoV) Situation Report—10" (PDF). World Health Organization (WHO). 30 de xaneiro de 2020. Consultado o 15 de marzo de 2020.

apps.who.int

World Health Organization, ed. (19 de febreiro de 2020). "Coronavirus disease 2019 (COVID-19): situation report, 29". World Health Organization (WHO). 10665/331118.

worldcat.org

Lai, Chih-Cheng; Shih, Tzu-Ping; Ko, Wen-Chien; Tang, Hung-Jen; Hsueh, Po-Ren (1 de marzo de 2020). "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges". International Journal of Antimicrobial Agents (en inglés) 55 (3): 105924. ISSN 0924-8579. PMID 32081636. doi:10.1016/j.ijantimicag.2020.105924.
Douaud, Gwenaëlle; Lee, Soojin; Alfaro-Almagro, Fidel; Arthofer, Christoph; Wang, Chaoyue; McCarthy, Paul; Lange, Frederik; Andersson, Jesper L. R.; Griffanti, Ludovica (2022-03-07). "SARS-CoV-2 is associated with changes in brain structure in UK Biobank". Nature (en inglés): 1–17. ISSN 1476-4687. doi:10.1038/s41586-022-04569-5.
Lauer, Stephen A.; Grantz, Kyra H.; Bi, Qifang; Jones, Forrest K.; Zheng, Qulu; Meredith, Hannah R.; Azman, Andrew S.; Reich, Nicholas G.; Lessler, Justin (10 de marzo de 2020). "The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application". Annals of Internal Medicine (en inglés). ISSN 0003-4819. PMC 7081172. PMID 32150748. doi:10.7326/M20-0504. Arquivado dende o orixinal o 24 de marzo de 2020. Consultado o 28 de marzo de 2020.
Gu, Jinyang; Han, Bing; Wang, Jian (27 de febreiro de 2020). "COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission". Gastroenterology. ISSN 0016-5085. PMID 32142785. doi:10.1053/j.gastro.2020.02.054.
Hamming, I.; Timens, W.; Bulthuis, M. L. C.; Lely, A. T.; Navis, G. J.; Goor, H. van (2004). "Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis". The Journal of Pathology (en inglés) 203 (2): 631–637. ISSN 1096-9896. PMID 15141377. doi:10.1002/path.1570.
Vogel, Gretchen (2020). "New blood tests for antibodies could show true scale of coronavirus pandemic". Science. ISSN 0036-8075. doi:10.1126/science.abb8028.
Salehi, Sana; Abedi, Aidin; Balakrishnan, Sudheer; Gholamrezanezhad, Ali (2020-03-14). "Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients". American Journal of Roentgenology (en inglés): 1–7. ISSN 0361-803X. PMID 32174129. doi:10.2214/AJR.20.23034.
Lee, Elaine Y. P.; Ng, Ming-Yen; Khong, Pek-Lan (24 de febreiro de 2020). "COVID-19 pneumonia: what has CT taught us?". The Lancet Infectious Diseases (en English) 0 (4): 384–385. ISSN 1473-3099. PMID 32105641. doi:10.1016/S1473-3099(20)30134-1. Consultado o 13 de marzo de 2020.
Parker-Pope, Tara (19 de marzo de 2020). "Deciding How Much Distance You Should Keep". The New York Times (en inglés). ISSN 0362-4331. Consultado o 20 de marzo de 2020.
Siemieniuk, Reed AC; Bartoszko, Jessica J; Ge, Long; Zeraatkar, Dena; Izcovich, Ariel; Kum, Elena; Pardo-Hernandez, Hector; Rochwerg, Bram; Lamontagne, Francois; Han, Mi Ah; Liu, Qin; Agarwal, Arnav; Agoritsas, Thomas; Chu, Derek K; Couban, Rachel; Darzi, Andrea; Devji, Tahira; Fang, Bo; Fang, Carmen; Flottorp, Signe Agnes; Foroutan, Farid; Ghadimi, Maryam; Heels-Ansdell, Diane; Honarmand, Kimia; Hou, Liangying; Hou, Xiaorong; Ibrahim, Quazi; Khamis, Assem; Lam, Bonnie; Loeb, Mark; Marcucci, Maura; McLeod, Shelley L; Motaghi, Sharhzad; Murthy, Srinivas; Mustafa, Reem A; Neary, John D; Qasim, Anila; Rada, Gabriel; Riaz, Irbaz Bin; Sadeghirad, Behnam; Sekercioglu, Nigar; Sheng, Lulu; Sreekanta, Ashwini; Switzer, Charlotte; Tendal, Britta; Thabane, Lehana; Tomlinson, George; Turner, Tari; Vandvik, Per O; Vernooij, Robin WM; Viteri-García, Andrés; Wang, Ying; Yao, Liang; Ye, Zhikang; Guyatt, Gordon H; Brignardello-Petersen, Romina (2020-07-30). "Drug treatments for covid-19: living systematic review and network meta-analysis". BMJ (BMJ): m2980. ISSN 1756-1833. doi:10.1136/bmj.m2980.
Kim, Peter S.; Read, Sarah W.; Fauci, Anthony S. (2020-12-01). "Therapy for Early COVID-19". JAMA (American Medical Association (AMA)) 324 (21): 2149. ISSN 0098-7484. doi:10.1001/jama.2020.22813.
Hsu, Jeremy (2020-11-19). "Covid-19: What now for remdesivir?". BMJ (BMJ): m4457. ISSN 1756-1833. doi:10.1136/bmj.m4457.
Day, Michael (17 de marzo de 2020). "Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists". BMJ (en inglés) 368: m1086. ISSN 1756-1833. PMID 32184201. doi:10.1136/bmj.m1086.
Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. (18 de marzo de 2020). "SARS-CoV-2 Infection in Children". New England Journal of Medicine (Massachusetts Medical Society). ISSN 0028-4793. PMID 32187458. doi:10.1056/nejmc2005073.
Douaud, Gwenaëlle; Lee, Soojin; Alfaro-Almagro, Fidel; Arthofer, Christoph; Wang, Chaoyue; McCarthy, Paul; Lange, Frederik; Andersson, Jesper L. R.; Griffanti, Ludovica (2022-03-07). "SARS-CoV-2 is associated with changes in brain structure in UK Biobank". Nature (en inglés): 1–17. ISSN 1476-4687. doi:10.1038/s41586-022-04569-5.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. (2020). "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study". The Lancet (Elsevier BV) 395 (10229): 1054–1062. ISSN 0140-6736. PMID 32171076. doi:10.1016/s0140-6736(20)30566-3.
Lazzerini, Marzia; Putoto, Giovanni (18 de marzo de 2020). "COVID-19 in Italy: momentous decisions and many uncertainties". The Lancet Global Health (en English) 0. ISSN 2214-109X. PMID 32199072. doi:10.1016/S2214-109X(20)30110-8.
"Virology: Coronaviruses". Nature 220 (5168): 650. 1968. Bibcode:1968Natur.220..650.. ISSN 0028-0836. doi:10.1038/220650b0.

worldometers.info

"Coronavirus (COVID-19) Mortality Rate". www.worldometers.info. 5 de marzo de 2020. Consultado o 23 de marzo de 2020.
"Coronavirus Age, Sex, Demographics (COVID-19)". www.worldometers.info. Arquivado dende o orixinal o 27 de febreiro de 2020. Consultado o 26 de febreiro de 2020.